are-20210201
0001035443false00010354432021-02-012021-02-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 1, 2021


ALEXANDRIA REAL ESTATE EQUITIES, INC.
(Exact name of registrant as specified in its charter)

Maryland1-1299395-4502084
(State or other jurisdiction of
incorporation)
(Commission File Number)(I.R.S. Employer Identification No.)

 26 North Euclid Avenue, Pasadena, California 91101
(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: (626) 578-0777
 
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐            Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.01 par value per share
ARE
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 2.02.  Results of Operations and Financial Condition.

On February 1, 2021, Alexandria Real Estate Equities, Inc. (the “Company”) issued a press release entitled “Alexandria Real Estate Equities, Inc. Reports Fourth Quarter and Year Ended December 31, 2020 Financial and Operating Results.”  The press release referred to certain supplemental information that is available on the Company’s website at www.are.com.  A copy of the press release and supplemental information are attached hereto as Exhibit 99.1.

The information contained in this Item 2.02, including the exhibit referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section.  Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01.  Financial Statements and Exhibits.

(d)  Exhibits.

99.1     Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Fourth Quarter and Year Ended December 31, 2020

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Forward-Looking Statements

This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act.  These statements include words such as “forecast,” “guidance,” “projects,” “estimates,” “anticipates,” “goals,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” or “will,” or the negative of these words or similar words.  Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement.  A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.  The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ALEXANDRIA REAL ESTATE EQUITIES, INC.
February 1, 2021By:/s/ Joel S. Marcus
Joel S. Marcus
Executive Chairman
By:/s/ Stephen A. Richardson
Stephen A. Richardson
Co-Chief Executive Officer
By:/s/ Peter M. Moglia
Peter M. Moglia
Co-Chief Executive Officer and
Co-Chief Investment Officer
By:/s/ Dean A. Shigenaga
Dean A. Shigenaga
President and Chief Financial Officer


q420frontcoverv31a.jpg


q420inthenewsav21a.jpg
i


q420onefifteensplashv21a.jpg
ii


q420gateway685splashv31a.jpg
iii


q420insidecoverv101a.jpg
iv


q420insidecoverdnav21a.jpg
v


q420metricsv51a.jpg
(1)Refer to “Annual rental revenue,” “Class A properties and AAA locations,” and “Investment-grade or publicly traded large cap tenants” in the “Definitions and reconciliations” of our Supplemental Information for additional details.
(2)Liquidity as of December 31, 2020. Refer to “Key credit metrics” of our Supplemental Information for additional details.
vi


q420balancesheetcoverv71a.jpg
(1)As of December 31, 2020. Refer to “Key credit metrics” of our Supplemental Information for additional details.
(2)Represents credit rating levels from Moody’s Investors Service and S&P Global Ratings in comparison to those of all publicly traded REITs (excluding mortgage REITs) as of December 31, 2020.
(3)Quarter annualized as of December 31, 2020. Represents the lowest in the past 10 years.
(4)As of December 31, 2020.
vii


q420socialresponsibilityv91a.jpg
(1)Source: Centers for Disease Control and Prevention, “Overdose Deaths Accelerating During COVID-19,” December 17, 2020.
viii


q420sustainabilityav141.jpg
(1)13 projects have been certified and another 38 projects are in process targeting WELL or Fitwel certification.
(2)Alexandria LaunchLabs® – New York City achieved the WELL Health-Safety Rating in October 2020.
(3)Relative to a 2015 baseline for buildings in operation that Alexandria directly manages.
(4)For buildings in operation that Alexandria indirectly and directly manages.
(5)Reflects sum of annual like-for-like progress from 2015 to 2019.
(6)Reflects progress for all buildings in operation in 2019 that Alexandria indirectly and directly manages.
ix

q220logo9a.jpg
Table of Contents
December 31, 2020
EARNINGS PRESS RELEASEPagePage
Fourth Quarter and Year Ended December 31, 2020, Financial and Operating Results
SUPPLEMENTAL INFORMATIONPagePage
External Growth / Investments in Real Estate
New Class A Development and Redevelopment Properties:
Internal Growth
Balance Sheet Management
Definitions and Reconciliations
This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Please refer to page 13 of this Earnings Press Release and our Supplemental Information for further information.

This document is not an offer to sell or a solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy our securities shall be made only by means of a prospectus approved for that purpose. Unless otherwise indicated, the “Company,” “Alexandria,” “ARE,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and our consolidated subsidiaries.
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2021
x

logo1a.jpg



Alexandria Real Estate Equities, Inc.
Reports:
4Q20 Net Income per Share – Diluted of $3.26;
4Q20 FFO per Share – Diluted, As Adjusted, of $1.84; and
Operational Excellence and Strong, Flexible Balance Sheet With Significant Liquidity

PASADENA, Calif. – February 1, 2021 – Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the fourth quarter and year ended December 31, 2020.
Key highlights
Operating results4Q204Q1920202019
Total revenues:
In millions$463.7 $408.1 $1,885.6 $1,531.3 
Growth13.6 %23.1 %
Net income attributable to Alexandria’s common stockholders – diluted
In millions$435.9 $199.6 $760.8 $351.0 
Per share$3.26 $1.74 $6.01 $3.12 
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted
In millions$246.6 $203.4 $923.8 $783.0 
Per share$1.84 $1.77 $7.30 $6.96 
Alexandria and our tenants at the vanguard and heart of the life science ecosystem
Bringing together our unique and pioneering strategic vertical platforms of essential Labspace® real estate, strategic venture investments, impactful thought leadership, and purposeful corporate responsibility, Alexandria is at the vanguard and heart of the vital life science ecosystem that is advancing solutions for COVID-19 and other key challenges to human health. Owing to the efforts of numerous Alexandria tenants, including Pfizer and Moderna, in developing and delivering safe and effective vaccines and therapies to people around the world, the inherent value and critical need for the life science industry has been globally recognized. The essential R&D engine of the biopharma industry continued with productivity and resilience throughout this past year. By maintaining continuous operations across our campuses and facilities, Alexandria has enabled our tenants, to continue to pursue their essential, mission-critical research, development, manufacturing, and commercialization efforts to solve the most pressing current and future healthcare challenges.

Strong and flexible balance sheet with significant liquidity
•Investment-grade credit ratings ranked in the top 10% among all publicly traded REITs as of December 31, 2020.
•Net debt and preferred stock to Adjusted EBITDA of 5.3x and fixed-charge coverage ratio of 4.6x represent the lowest and highest, respectively, in the past 10 years.
•$4.1 billion of liquidity as of December 31, 2020.
•No debt maturities prior to 2024.
•10.6 years weighted-average remaining term of debt as of December 31, 2020.






Continued dividend strategy to share growth in cash flows with stockholders
Common stock dividend declared for 4Q20 of $1.09 per common share, aggregating $4.24 per common share for the year ended December 31, 2020, up 24 cents, or 6%, over the year ended December 31, 2019. Our FFO payout ratio of 60% for the three months ended December 31, 2020, allows us to share growth in cash flows from operating activities with our stockholders while also retaining a significant portion for reinvestment.

A REIT industry-leading, high-quality tenant roster
•55% of annual rental revenue from investment-grade or publicly traded large cap tenants.
•Weighted-average remaining lease term of 7.6 years.

Key strategic transactions that generated capital for investment into our highly leased value-creation pipeline and strategic acquisitions
During 4Q20, we completed two strategic transactions that generated capital aggregating $874.6 million for investment into our highly leased development and redevelopment projects and strategic acquisitions:
•Sale of 70% ownership interest in our properties at 1201 and 1208 Eastlake Avenue East and 199 East Blaine Street in our Lake Union submarket for an aggregate sales price of $314.5 million, representing a capitalization rate of 4.2% (cash basis), and setting a new record high in Seattle of $1,399 per RSF; and
•Disposition of two tech office buildings at 510 Townsend Street and 505 Brannan Street in our SoMa submarket for an aggregate sales price of $560.2 million, or $1,263 per RSF, representing capitalization rates of 5.3% and 5.0% (cash basis), and a gain on sale of $151.9 million.

Continued solid net operating income and internal growth
•Net operating income (cash basis) of $1.2 billion for 4Q20 annualized, up $146.1 million, or 14.4%, compared to 4Q19 annualized.
•94% of our leases contain contractual annual rent escalations approximating 3%.
•Same property net operating income growth:
•2.7% and 5.0% (cash basis) for 4Q20 over 4Q19.
•2.6% and 5.1% (cash basis) for 2020 over 2019.
•Continued solid leasing activity and rental rate growth during 2020 over expiring rates on renewed and re-leased space, representing our highest annual rental rate increases during the past 10 years:
4Q202020
Total leasing activity – RSF1,369,599 4,358,846 
Leasing of development and redevelopment space – RSF488,154 1,012,364 
Lease renewals and re-leasing of space:
RSF (included in total leasing activity above)699,916 2,556,833 
Rental rate increases29.8%37.6%
Rental rate increases (cash basis)10.7%18.3%


•Guidance ranges for expected 2021 rental rate increases on lease renewals and re-leasing of space are 29.0% to 32.0%, and 16.0% to 19.0% (cash basis).
1

q220logo9a.jpg
Fourth Quarter and Year Ended December 31, 2020, Financial and Operating Results (continued)
December 31, 2020
High-quality revenues and cash flows, strong margins, and operational excellence
Percentage of annual rental revenue in effect from investment-grade or publicly traded large cap tenants55 %
Occupancy of operating properties in North America94.6 %
(1)
Operating margin71 %
Adjusted EBITDA margin69 %
Weighted-average remaining lease term:
All tenants7.6years
Top 20 tenants11.0years
(1)Includes 970,199 RSF, or 3.1%, of vacancy in our North America markets, representing lease-up opportunities that will contribute to growth in cash flows at recently acquired properties. Excluding these acquired vacancies, occupancy of operating properties in North America was 97.7% as of December 31, 2020. Refer to “Occupancy” of our Supplemental Information for additional details regarding vacancy from recently acquired properties.

Sustained strength in tenant collections during the ongoing COVID-19 pandemic
•We have collected rents and tenant recoveries as follows:
•99.8% for April 1, 2020 through December 31, 2020; and
•99.2% for January 2021 as of January 29, 2021.
•As of December 31, 2020, our tenant receivables balance was $7.3 million.


Key items included in operating results
Key items included in net income attributable to Alexandria’s common stockholders:
4Q204Q194Q204Q192020201920202019
(In millions, except per share amounts)
AmountPer Share – DilutedAmountPer Share – Diluted
Unrealized gains on non-real estate investments$233.5 $148.3 $1.75 $1.29 $374.0 $161.5 $2.96 $1.44 
Gain on sales of real estate152.5 0.5 1.14 — 154.1 0.5 1.22 — 
Impairment of real estate(25.2)(12.3)(0.19)(0.11)(55.7)(12.3)(0.44)(0.11)
Impairment of non-real estate investments— (10.0)— (0.09)(24.5)(17.1)(0.19)(0.15)
Loss on early extinguishment of debt(7.9)— (0.06)— (60.7)(47.6)(0.48)(0.42)
Loss on early termination of interest rate hedge agreements— — — — — (1.7)— (0.02)
Termination fee— — — — 86.2 — 0.68 — 
Acceleration of stock compensation expense due to executive officer resignation— — — — (4.5)— (0.04)— 
Preferred stock redemption charge— — — — — (2.6)— (0.02)
Total
$352.9 $126.5 $2.64 $1.09 $468.9 $80.7 $3.71 $0.72 

Strategic acquisitions with significant value-creation opportunities in key submarkets
•During 4Q20, we completed acquisitions of 16 properties in key submarkets aggregating 3.3 million SF, with significant value-creation opportunities including, 1.9 million RSF of future developments, 383,396 RSF of active redevelopments, and 1.0 million of operating RSF, currently 80% occupied, for an aggregate purchase price of $580.7 million.
•In January 2021, we completed the acquisition of 401 Park Drive, 201 Brookline Avenue and one future development opportunity, as described in further detail below.

Acquisition of 401 Park Drive and 201 Brookline Avenue
•In January 2021, we acquired 401 Park Drive, 201 Brookline Avenue, and one future development opportunity, located in the heart of our Greater Boston life science cluster market, for a purchase price of $1.48 billion. The future collaborative life science campus, aggregating 1.8 million SF, consists of the following:
•401 Park Drive (operating property with future redevelopment opportunity):
•Highly amenitized Class A office/R&D building aggregating 973,145 RSF, currently 93% occupied with a weighted-average remaining lease term of 8.8 years;
•50% of annual rental revenue generated from investment-grade tenants;
•In-place rents are 38% below market; 30% of the RSF has a weighted-average remaining lease term of 3.3 years with in-place rents approximately 41% below market;
•Initial stabilized yields of 5.7% and 4.5% (cash basis); and
•Future opportunity to redevelop up to 221,000 RSF, or 23% of the building, to office/laboratory space.
•201 Brookline Avenue (active development):
•Office/laboratory building undergoing ground-up development, aggregating 510,116 RSF, targeting initial occupancy in 2022; and
•17% pre-leased to high-quality tenants.
•Future development opportunity for one office/laboratory building for which we are pursuing net new entitlement rights totaling approximately 400,000 SF of office/laboratory along with retail and common spaces.

Highly leased value-creation pipeline, including COVID-19-focused R&D spaces
•Current and pre-leased near-term projects aggregating 4.8 million RSF, including COVID-19-focused R&D spaces, are highly leased/negotiating at 78% and will generate significant revenues and cash flows.
•We commenced development and redevelopment of four projects aggregating 609,797 RSF during 4Q20 and two projects aggregating 640,116 RSF during January 2021.
•Key development and redevelopment projects placed into service in 4Q20:
•63,774 RSF at our redevelopment project at 9877 Waples Street in our Sorrento Mesa submarket, 100% leased to Cue Health Inc.; and
•96,463 RSF at our development project at the Alexandria Center® for Life Science – San Carlos in our Greater Stanford submarket, leased to ChemoCentryx, Inc.
•Annual net operating income (cash basis), including our share of unconsolidated real estate joint ventures, is expected to increase by $28 million upon the burn-off of initial free rent on recently delivered projects.

2

q220logo9a.jpg
Fourth Quarter and Year Ended December 31, 2020, Financial and Operating Results (continued)
December 31, 2020
Balance sheet management

Key metrics as of December 31, 2020
•$31.9 billion of total market capitalization.
•$24.4 billion of total equity capitalization.
•$4.1 billion of liquidity.
4Q20Goal
QuarterTrailing4Q21
Annualized12 MonthsAnnualized
Net debt and preferred stock to Adjusted EBITDA5.3x5.5xLess than or equal to 5.2x
Fixed-charge coverage ratio4.6x4.4xGreater than or equal to 4.5x
Value-creation pipeline of new Class A development and redevelopment projects as a percentage of gross investments in real estate4Q20
Current and pre-leased near-term projects 78% leased/negotiating
8%
Income-producing/potential cash flows/covered land play(1)
7%
Land
3%
(1)Includes projects that have existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating campuses.

Key capital events
•In October 2020, we amended our unsecured senior line of credit. Key changes include the following:
New AgreementChange
Commitments available for borrowing$3.0 billion
Up $800 million
Interest rateLIBOR+0.825%Added a 0% LIBOR floor
Maturity dateJanuary 6, 2026Extended 2 years
•In December 2020, we increased the aggregate amount we may issue under our commercial paper program from $1.0 billion to $1.5 billion. Borrowings under our commercial paper program are backed by our $3.0 billion unsecured senior line of credit.
•During 4Q20, our common equity transactions included the following:
•We issued 1.8 million shares of common stock to settle our remaining forward equity sales agreements that were outstanding at the beginning of the quarter and received net proceeds of $267 million.
•We issued 1.5 million shares of common stock under our ATM program at a price of $159.09 per share (before underwriting discounts) and received net proceeds of $235.0 million.
•We sold 362 thousand shares under our ATM program subject to forward equity sales agreements that remain outstanding at a price of $159.09 per share (before underwriting discounts). We expect to settle these forward equity sales agreements in 2021 and receive net proceeds of approximately $56.3 million.
•The remaining availability of $547.3 million under this ATM program expired in December 2020 concurrently with the expiration of the associated shelf registration. In January 2021, we filed a new shelf registration and we expect to file a new ATM program soon in 2021.
Key capital events (continued)
•In December 2020, we extinguished two secured notes payable aggregating $108.2 million, due in 2023 with a weighted-average interest rate of 3.67%, and recognized losses on early extinguishment of debt aggregating $7.3 million. As a result of these extinguishments, we have no debt maturing until 2024.
•In January 2021, we entered into forward equity sales agreements aggregating $1.1 billion to sell an aggregate of 6.9 million shares of our common stock (including the exercise of underwriters’ option) at a public offering price of $164.00 per share, before underwriting discounts and commissions. We expect to settle these forward equity sales agreements in March 2021.

Investments
•Our investments in publicly traded companies and privately held entities aggregated a carrying amount of $1.6 billion, including an adjusted cost basis of $835.4 million and unrealized gains of $775.7 million, as of December 31, 2020.
•Investment income of $255.1 million during 4Q20 included $21.6 million in realized gains and $233.5 million in unrealized gains.

Industry and corporate responsibility leadership: catalyzing and leading the way for positive change to benefit human health and society

Industry leadership
•In November 2020, Alexandria was ranked as the #1 public REIT for construction-in-progress in 2019 from Engineering News-Record’s (ENR) Top 50 List. ENR recognizes leaders in the construction industry, and its top ranking of our construction activity highlights our commitment to creating and delivering life-changing and essential facilities to our tenant community.
•In December 2020, we achieved the following in the 2020 Global Real Estate Sustainability Benchmark (“GRESB”) Real Estate Assessment: (i) #1 global ranking in the Science & Technology sector, (ii) #1 global ranking and 5 Star Rating (out of 5 stars) in our Diversified Listed Peer Group for highly sustainable development initiatives, and (iii) our third consecutive “A” disclosure score.
•In January 2021, Alexandria Venture Investments, our strategic venture capital platform, was recognized for a fourth consecutive year as the most active biopharma corporate investor by new deal volume from 2019 to 2020 by Silicon Valley Bank in its “Healthcare Investments and Exits: Annual Report 2021.” Alexandria’s venture activity provides us with, among other things, mission-critical data and knowledge of innovations and trends.

Pioneering social responsibility initiatives to continue to drive unique, disruptive, and highly impactful solutions to tackle some of society’s most complex and pressing challenges
Alexandria is profoundly committed to driving forward significant collaborative and innovative solutions to address some of today’s most urgent and widespread societal challenges, including the COVID-19 pandemic, the opioid epidemic, and the educational achievement gap.

3

q220logo9a.jpg
Fourth Quarter and Year Ended December 31, 2020, Financial and Operating Results (continued)
December 31, 2020
At the vanguard and heart of the life science ecosystem’s fight against COVID-19
•As a testament to our comprehensive and industry-leading COVID‑19 prevention guidelines and practices, in October 2020, we became the first-ever company to achieve a Fitwel Viral Response Certification with Distinction, the highest designation within the new Viral Response Module developed by the world’s leading healthy building certification system. Additionally, in November 2020, we achieved the world’s first WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs® – New York City. This latest evidence-based, third-party verified rating further affirms our longstanding and robust practices to help keep our tenants, employees, visitors, service providers, and key industry stakeholders healthy and safe.
•Throughout the COVID-19 pandemic, Alexandria has been a critical partner to several impactful organizations supporting communities adversely affected by the COVID-19 pandemic. In total, Alexandria has donated more than $1 million to non-profit organizations on the front lines of combating the devastating impact of the COVID-19 pandemic, including Robin Hood, New York City’s largest poverty-fighting organization. As a member of the Robin Hood Board of Directors, Joel Marcus has played a key leadership role in the distribution of over $60 million to 575 organizations across all five New York City boroughs, providing critical emergency support for New Yorkers in need through food, housing, financial assistance, job security, and more.
•In lieu of tenant holiday gifts, in December 2020, Alexandria made donations to several regional COVID-19-related non-profit programs, including Seattle Foundation’s COVID-19 Relief Fund, Robin Hood COVID-19 Relief Fund, SF New Deal COVID-19 Relief for San Francisco, Nourish Now in Maryland, and the Greg Hill Foundation’s Restaurant Strong Fund in Boston.

Pioneering a groundbreaking, data-driven, and evidence-based model to help solve the opioid epidemic
•Determined to reverse the trajectory of the U.S. opioid epidemic, which is one of the most pervasive public health challenges in our nation’s history, Alexandria partnered with Verily Life Sciences to establish an innovative, non-profit healthcare ecosystem dedicated to the full and sustained recovery of people living with addiction. Together, we pioneered a fully integrated campus in Dayton, Ohio, to house an evidence-based comprehensive treatment model encompassing a full continuum of care with dedicated facilities and services for treatment, residential housing, group therapy, family reunification, workforce development programs, job placement, and community transition.
•Over the last year, we completed construction of the OneFifteen Outpatient Clinic; the Crisis Stabilization Unit; and most recently, OneFifteen Living, the residential housing component that opened in late 2020.
•Overdose deaths continue to rise dramatically during the COVID-19 pandemic, demonstrating the tremendous need for the OneFifteen ecosystem. Since opening in the fall of 2019, OneFifteen has made a positive and comprehensive impact on the local community and the way addiction is treated, seeing approximately 2,200 patients in 2020, including over 1,150 people during the three months ended December 31, 2020. It is our hope that OneFifteen’s unique approach to treatment will serve as a model of recovery for the rest of the country to replicate.

Building educational foundations for students to pave paths for long-term success and close the achievement gap
•Alexandria is deeply committed to driving educational opportunities and providing the support and resources needed to build the foundations for underserved, low-income students to succeed and become engaged and leading members of society. Understanding that education is one of the most fundamental foundations for a safe, healthy, and good life and essential for opportunity and economic mobility, we have forged deep partnerships in our communities with highly impactful organizations that provide holistic educational resources to underserved populations.
•In December 2020, Alexandria celebrated the culmination of the Emily Krzyzewski Center’s $15 million Game Changer Campaign, in which Alexandria played a critical leadership role. The Emily K Center paves a path to success in higher education for academically focused, low-income K–12 students in Durham, North Carolina. Students receive holistic support that encompasses academic skills development, personal management and leadership training, college planning, and career exploration. Of those who complete Emily K’s Scholars to College program, nearly 100% are accepted to college each year.
•The campaign funds will support ongoing programs to prepare students for life-changing college access while bolstering their achievement and developing their character and leadership; an endowment to ensure support for students in years to come; and a new 7,500 square foot facility designed for the specific needs of college-access programs to provide much needed classroom space as well as rooms for quiet study and one-on-one advising and financial aid discussions.


4

Select 2020 Financial Highlights
q220logo9a.jpg
December 31, 2020
q420highlights2020v141a.jpg
(1)Source: Company filings and FactSet as of December 31, 2020.
(2)Rental rate increases of 37.6% and 18.3% (cash basis) represent our highest annual increases on renewed and re-leased space in the last 10 years.
(3)Represents tenant collections from April 1, 2020 to December 31, 2020.
(4)Ranking based on 2019 construction-in-progress for publicly held REITs.
5


q420tenantscovidav71.jpg
Represents an illustrative subset of approximately 100 tenants focused on COVID-19-related efforts, with some of these companies working on multiple efforts that span testing, treatment, and/or vaccine development.
(1)Source: National Institutes of Health, “NIH launches clinical trials network to test COVID-19-related vaccines and other preventive tools,” July 8, 2020.
6


q420tenantscovidbv81a.jpg
(1)As of January 29, 2021. Source: U.S. Department of Health & Human Services. Federal funding presented includes the total commitment value.
(2)Source: U.S. Food and Drug Administration, “FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine,” December 18, 2020.
7

Alexandria Fighting COVID-19 on Multiple Fronts
q220logo9a.jpg
December 31, 2020


Alexandria and our innovative tenants are at the vanguard and heart of the life science ecosystem advancing solutions for COVID-19

Safe and effective vaccines and therapies, in addition to widespread testing, continue to be critically needed to combat the global COVID-19 pandemic. By maintaining essential continuous operations across our campuses, Alexandria has enabled several of our life science tenants to pursue mission-critical COVID-19-related research and development. The heroic work being done by so many of our tenants and campus community members to help test for, treat, and prevent COVID-19, as well as provide medical supplies and protective equipment to neighboring hospitals, is profound and inspiring. We are currently tracking approximately 100 tenants across our cluster markets that have contributed meaningful time and resources to advancing solutions for COVID-19.

Developing preventative vaccines

A prophylactic vaccine is critically needed to resolve the global COVID-19 pandemic. As such, researchers around the world are working tirelessly to develop a safe and effective vaccine in record time. Furthermore, to help expedite the development, manufacturing, and distribution of COVID-19 vaccines, the U.S. government initiated an unprecedented public-private collaboration, allocating several billions of dollars to these efforts.

This support along with the internal vaccine development expertise and innovative technology platforms of our tenants Pfizer Inc. (in partnership with BioNTech) and Moderna, Inc. (in partnership with the National institutes of Health), culminated in the FDA providing Emergency Use Authorization (“EUA”) in December 2020 for their respective mRNA based COVID-19 vaccines. The U.S. has begun a large-scale COVID-19 vaccination campaign and will continue to roll out vaccines across the nation, prioritizing frontline and essential workers, the elderly, and individuals considered high-risk.

Additional tenants, including AstraZeneca plc, Emergent BioSolutions Inc., FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline, Johnson & Johnson, Novavax, Inc., and Sanofi, have similarly received strong government support for their efforts in the development, manufacturing, and/or distribution of COVID-19 vaccines. Many of these companies will report critical trial data over the coming months, which, if positive, could help bolster the widespread delivery of a safe and effective COVID-19 vaccine around the world.

Advancing new and repurposed therapies

Safe and effective therapies are important for mitigating the impact of COVID-19, decreasing hospitalizations, and improving patient outcomes overall. On October 22, 2020, the FDA approved Veklury® (remdesivir), developed by our tenant Gilead Sciences, Inc., as the first antiviral treatment approved for COVID-19 patients requiring hospitalization. Subsequently, in November 2020, the FDA granted EUAs to tenant Eli Lilly and Company’s bamlanivimab for the treatment of newly infected high-risk patients with mild or moderate disease, as well as to Regeneron Pharmaceutical’s antibody cocktail for a similar indication.

In addition, over 300 experimental therapies to treat COVID-19 are being studied in over 900 clinical trials around the world, as well as over more than 150 therapeutic candidates in preclinical development. A substantial number of these programs are sponsored by our tenants, including the following:

•Vir Biotechnology, Inc. and GlaxoSmithKline announced on October 6, 2020, that their most advanced antibody therapy for the early treatment of patients with COVID-19 has entered Phase III and that they expect complete results in the first quarter of 2021.
•AbbVie Inc., Amgen, AstraZeneca plc, Atreca Inc., Enanta Pharmaceuticals, Inc., Novartis AG, and Pfizer Inc. are similarly endeavoring to develop novel therapies and repurpose existing and investigational drugs to provide near-term treatments for moderate and severe COVID-19 patients and those at highest risk.

Improving testing quality and capacity

Abbott Laboratories, Adaptive Biotechnologies Corporation, Color, Cue Health Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Quidel Corporation, Roche, Thermo Fisher Scientific Inc., Verily Life Sciences, and others are working to improve testing quality, capacity, and turnaround time to more effectively determine who has an active COVID-19 infection, who has been exposed to the virus, and who has developed immunity against it. The increased availability of widespread COVID-19 testing is critical for curtailing the pandemic and facilitating a safer reopening of workplaces, communities, and society overall.
8

Acquisitions
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)


PropertySubmarket/MarketDate of
Purchase
Number of PropertiesOperating
Occupancy
Square FootagePurchase Price
Future DevelopmentActive RedevelopmentOperating With Future Development/ RedevelopmentOperating
Completed in YTD 3Q203986 %3,197,313 716,155 1,236,177 3,325,313 $1,982,749 
(1)
Completed in 4Q20:
6420 and 6450 Sequence DriveSorrento Mesa/San Diego11/13/20289 
(2)
709,000 — 202,915 115,285 169,698 
(2)
380 and 420 E StreetSeaport Innovation District/Greater Boston10/29/202100 1,000,000 
(3)
— 195,506 — 168,500 
(4)
3450 and 3460 Hillview AvenueGreater Stanford/San Francisco10/6/202100 — — 76,951 — 65,748 
(4)
700 Quince Orchard RoadGaithersburg/Maryland10/23/201N/A— 169,420 
(5)
— — 43,000 
Other962 175,400 213,976 51,255 389,992 133,707 
(4)
1680 1,884,400 383,396 526,627 505,277 580,653 
2020 acquisitions5585 %5,081,713 1,099,551 1,762,804 3,830,590 $2,563,402 


(1)Refer to our quarterly report on Form 10-Q for the period ended September 30, 2020, filed on October 26, 2020, for transactions and related yield information.
(2)The two operating properties are currently 89% occupied, and upon completion of renovations, a lease for 60,432 RSF will commence in 2H21, which will increase occupancy to 100%. We expect to achieve unlevered initial stabilized yields of 7.2% and 6.2% (cash basis) for these operating properties.
(3)Represents total square footage upon completion of development of a new Class A property. Square footage presented includes 195,506 RSF of buildings currently in operation at properties with inherent future development opportunities. We intend to demolish the existing property upon expiration of the existing in-place leases and commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
(4)We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction.
(5)Refer to “New Class A development and redevelopment properties: current projects” of our Supplemental Information for additional details.

9

Acquisitions (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

PropertySubmarket/MarketDate of
Purchase
Number of PropertiesOperating
Occupancy
Square FootagePurchase Price
Future DevelopmentActive Development/RedevelopmentOperating With Future Development/ RedevelopmentOperating
2021 acquisitions
Completed:
Alexandria Center® for Life Science – Fenway
Fenway/Greater Boston1/29/21293%
(1)
305,000 510,116 — 973,145 $1,483,200 
(1)
840 Winter StreetRoute 128/Greater Boston1/20/211100— 130,000 30,009 — 58,126 
(2)
OtherVariousVarious2N/A— 185,669 — — 60,750 
(2)
593%305,000 825,785 30,009 973,145 1,602,076 
Pending:
Mercer Mega Block
Lake Union/Seattle
TBD(3)
—N/A800,000 — — — 143,500 
TBD954,424 
2021 acquisitions$2,700,000 
2021 guidance range$2,450,000 – $2,950,000


(1)Refer to page 2 in our Earnings Press Release for additional information.
(2)We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction.
(3)We continue to diligently work through various long-lead-time due diligence items, with certain deadlines extending into 2021. We are working toward completion of all due diligence items as soon as possible.

10

Dispositions
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
PropertySubmarket/MarketDate of SaleInterest SoldRSFSales PriceSales Price per RSFGain
Completed in YTD 3Q20536,152 $252,454 $1,603 
Completed in 4Q20:
510 Townsend Street and 505 Brannan StreetSoMa/San Francisco11/20/20100%443,479 560,162 
(1)
$1,263 151,871 
1201 and 1208 Eastlake Avenue East and 199 East Blaine Street
Lake Union/Seattle11/24/2070%321,218 314,466 
(2)
$1,399 
(3)
OtherVariousVarious100%44,855 10,250 N/A615 
809,552 884,878 152,486 
2020 dispositions1,345,704 $1,137,332 $154,089 

(1)We completed the dispositions of these two tech office properties at capitalization rates of 5.3% and 5.0% (cash basis) based on annualized net operating income and net operating income (cash basis), respectively, for the three months ended September 30, 2020.
(2)This transaction represents capitalization rate of 4.2%, based on annualized net operating income and net operating income (cash basis) for the three months ended December 31, 2020.
(3)This sale of a partial interest represents consideration in excess of book value aggregating $211.3 million. We retained control over this real estate joint venture, and therefore, we continue to consolidate these properties. For consolidated joint ventures, we account for the consideration in excess of net book value of the interest sold as an equity transaction, with no gain or loss recognized in earnings.
11

Guidance
q220logo9a.jpg
December 31, 2020
(Dollars in millions, except per share amounts)
On January 5, 2021, we issued a current report on Form 8-K providing updates to key 2021 guidance items in connection with our forward equity offering. The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2021. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. Also, refer to our discussion of “forward-looking statements” on page 12 of this Earnings Press Release for additional details.


Projected 2021 Earnings per Share and Funds From Operations per Share Attributable to Alexandria’s Common Stockholders – Diluted
Earnings per share(1)
$2.14 to $2.34
Depreciation and amortization of real estate assets
5.50
Allocation to unvested restricted stock awards
(0.04)
Funds from operations per share(2)
$7.60 to $7.80
Midpoint
$7.70

Key Assumptions
LowHigh
Occupancy percentage in North America as of December 31, 202195.6%96.2%
Lease renewals and re-leasing of space:
Rental rate increases
29.0%32.0%
Rental rate increases (cash basis)
16.0%19.0%
Same property performance:
Net operating income increase
1.0%3.0%
Net operating income increase (cash basis)
4.0%6.0%
Straight-line rent revenue
$114 $124 
General and administrative expenses$146 $151 
Capitalization of interest
$167 $177 
Interest expense
$133 $143 

Key Credit Metrics2021 Guidance
Net debt and preferred stock to Adjusted EBITDA – 4Q21 annualized Less than or equal to 5.2x
Fixed-charge coverage ratio – 4Q21 annualizedGreater than or equal to 4.5x

Key Sources and Uses of Capital
RangeMidpointCertain
Completed Items
Sources of capital:
Net cash provided by operating activities after dividends$210 $250 $230 
Incremental debt730 740 735 
2020 debt capital proceeds held in cash150 250 200 
Real estate dispositions and partial interest sales(3)
1,250 1,500 1,375 
Common equity1,700 2,100 1,900 $1,141 
(4)
Total sources of capital$4,040 $4,840 $4,440 
Uses of capital:
Construction$1,590 $1,890 $1,740 
Acquisitions2,450 2,950 2,700 $1,602 
Total uses of capital$4,040 $4,840 $4,440 
Incremental debt (included above):
Issuance of unsecured senior notes payable(5)
$700 $1,100 $900 
Unsecured senior line of credit, commercial paper program, and other30 (360)(165)
Incremental debt$730 $740 $735 

(1)Excludes unrealized gains or losses after December 31, 2020, that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.
(2)Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in “Definitions and reconciliations” of our Supplemental Information for additional details.
(3)In December 2020, three office buildings aggregating 146,842 RSF met the criteria to be classified as held for sale. We expect to complete the sale of these properties in 2021 for a total estimated sales price of $78.1 million, including the buyer’s assumption of a $28.2 million secured note payable related to one of the buildings. Upon the buildings being classified as held for sale, we recognized impairment charges aggregating $25.2 million.
(4)Refer to "Key capital events" on page 3 of this Earnings Press Release for additional information on our January 2021 forward equity offering and our remaining outstanding forward equity contracts issued under our ATM program.
(5)In addition to our guidance range, we may seek opportunities to refinance our $650 million unsecured senior notes payable green bond due in 2024 prior to its maturity, subject to market conditions.


12

q220logo9a.jpg
Earnings Call Information and About the Company
December 31, 2020
We will host a conference call on Tuesday, February 2, 2021, at 3:00 p.m. Eastern Time (“ET”)/noon Pacific Time (“PT”), which is open to the general public, to discuss our financial and operating results for the fourth quarter and year ended December 31, 2020. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 3:00 p.m. ET/noon PT and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the “For Investors” section. A replay of the call will be available for a limited time from 5:00 p.m. ET/2:00 p.m. PT on Tuesday, February 2, 2021. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 10149959.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the fourth quarter and year ended December 31, 2020, is available in the “For Investors” section of our website at www.are.com or by following this link: http://www.are.com/fs/2020q4.pdf.

For any questions, please contact Joel S. Marcus, executive chairman and founder; Stephen A. Richardson, co-chief executive officer; Peter M. Moglia, co-chief executive officer and co-chief investment officer; Dean A. Shigenaga, president and chief financial officer; or Sara M. Kabakoff, vice president – communications, at (626) 578-0777; or Paula Schwartz, managing director of Rx Communications Group, at (917) 322-2216.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (“REIT”), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (“SF”). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

***********

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2021 earnings per share attributable to Alexandria’s common stockholders – diluted, 2021 funds from operations per share attributable to Alexandria’s common stockholders – diluted, net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” or “will,” or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties, assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets (including the impact of the ongoing COVID-19 pandemic), our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated, we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

For additional discussion of the risks and other potential impacts posed by the outbreak of the COVID-19 pandemic and uncertainties we, our tenants, and the global and national economies face as a result, see the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K filed with the SEC on February 1, 2021.

Alexandria®, Lighthouse Design® logo, Building the Future of Life-Changing Innovation™, Labspace®, Alexandria Center®, Alexandria Technology Square®, Alexandria Technology Center®, Alexandria Innovation Center®, LaunchLabs®, and That’s What’s in Our DNA™ are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names, trademarks, and logos referenced herein are the property of their respective owners.
13

Consolidated Statements of Operations
q220logo9a.jpg
December 31, 2020
(Dollars in thousands, except per share amounts)
 Three Months EndedYear Ended
 12/31/20

9/30/206/30/203/31/2012/31/1912/31/2012/31/19
Revenues:       
Income from rentals$461,335 $543,412 
(1)
$435,856 $437,605 $404,721 $1,878,208 $1,516,864 
Other income2,385 1,630 1,100 2,314 3,393 7,429 14,432 
Total revenues463,720 545,042 436,956 439,919 408,114 1,885,637 1,531,296 
Expenses:
Rental operations136,767 140,443 123,911 129,103 121,852 530,224 445,492 
General and administrative32,690 36,913 31,775 31,963 29,782 133,341 108,823 
Interest37,538 43,318 45,014 45,739 45,493 171,609 173,675 
Depreciation and amortization177,750 176,831 168,027 175,496 140,518 698,104 544,612 
Impairment of real estate25,177 7,680 13,218 2,003 12,334 48,078 12,334 
Loss on early extinguishment of debt7,898 
(2)
52,770 — — — 60,668 47,570 
Total expenses417,820 457,955 381,945 384,304 349,979 1,642,024 1,332,506 
Equity in earnings (losses) of unconsolidated real estate joint ventures3,593 3,778 3,893 (3,116)4,777 8,148 10,136 
Investment income (loss)255,137 3,348 184,657 (21,821)152,667 421,321 194,647 
Gain on sales of real estate152,503 1,586 — — 474 154,089 474 
Net income457,133 95,799 243,561 30,678 216,053 827,171 404,047 
Net income attributable to noncontrolling interests(15,649)(14,743)(13,907)(11,913)(13,612)(56,212)(40,882)
Net income attributable to Alexandria Real Estate Equities, Inc.’s stockholders441,484 81,056 229,654 18,765 202,441 770,959 363,165 
Dividends on preferred stock— — — — — — (3,204)
Preferred stock redemption charge— — — — — — (2,580)
Net income attributable to unvested restricted stock awards
(5,561)(1,730)(3,054)(1,925)(2,823)(10,168)(6,386)
Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders$435,923 $79,326 $226,600 $16,840 $199,618 $760,791 $350,995 
Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders:
Basic$3.26 $0.64 $1.82 $0.14 $1.75 $6.03 $3.13 
Diluted$3.26 $0.63 $1.82 $0.14 $1.74 $6.01 $3.12 
Weighted-average shares of common stock outstanding:
Basic133,688 124,901 124,333 121,433 114,175 126,106 112,204 
Diluted133,827 125,828 124,448 121,785 114,974 126,490 112,524 
Dividends declared per share of common stock
$1.09 $1.06 $1.06 $1.03 $1.03 $4.24 $4.00 

(1)Includes a termination fee aggregating $89.5 million related to the termination of a future lease at our 88 Bluxome Street development project.
(2)Includes $7.3 million related to the extinguishment of two secured notes payable aggregating $108.2 million, due in 2023 with a weighted-average interest rate of 3.67%, and $651 thousand related to the amendment of our unsecured senior line of credit.
14

Consolidated Balance Sheets
q220logo9a.jpg
December 31, 2020
(In thousands)
12/31/209/30/206/30/203/31/2012/31/19
Assets    
Investments in real estate$18,092,372 $17,600,648 $16,281,125 $15,832,182 $14,844,038 
Investments in unconsolidated real estate joint ventures332,349 330,792 326,858 325,665 346,890 
Cash and cash equivalents568,532 446,255 206,860 445,255 189,681 
Restricted cash29,173 38,788 34,680 43,116 53,008 
Tenant receivables7,333 7,641 7,208 14,976 10,691 
Deferred rent722,751 719,552 688,749 663,926 641,844 
Deferred leasing costs272,673 266,440 274,483 269,458 270,043 
Investments1,611,114 1,330,945 1,318,465 1,123,482 1,140,594 
Other assets 1,191,581 1,169,610 930,680 983,875 893,714 
Total assets$22,827,878 $21,910,671 $20,069,108 $19,701,935 $18,390,503 
Liabilities, Noncontrolling Interests, and Equity
Secured notes payable$230,925 $342,363 $344,784 $347,136 $349,352 
Unsecured senior notes payable7,232,370 7,230,819 6,738,486 6,736,999 6,044,127 
Unsecured senior line of credit and commercial paper99,991 249,989 440,000 221,000 384,000 
Accounts payable, accrued expenses, and other liabilities
1,669,832 1,609,340 1,343,181 1,352,554 1,320,268 
Dividends payable150,982 143,040 133,681 129,981 126,278 
Total liabilities9,384,100 9,575,551 9,000,132 8,787,670 8,224,025 
Commitments and contingencies
Redeemable noncontrolling interests11,342 11,232 12,122 12,013 12,300 
Alexandria Real Estate Equities, Inc.’s stockholders’ equity:
Common stock
1,367 1,333 1,246 1,243 1,208 
Additional paid-in capital11,730,970 10,711,119 9,443,274 9,336,949 8,874,367 
Accumulated other comprehensive loss(6,625)(10,638)(13,080)(15,606)(9,749)
Alexandria Real Estate Equities, Inc.’s stockholders’ equity11,725,712 10,701,814 9,431,440 9,322,586 8,865,826 
Noncontrolling interests1,706,724 1,622,074 1,625,414 1,579,666 1,288,352 
Total equity13,432,436 12,323,888 11,056,854 10,902,252 10,154,178 
Total liabilities, noncontrolling interests, and equity
$22,827,878 $21,910,671 $20,069,108 $19,701,935 $18,390,503 

15

Funds From Operations and Funds From Operations per Share
q220logo9a.jpg
December 31, 2020
(In thousands)
The following table presents a reconciliation of net income (loss) attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with generally accepted accounting principles (“GAAP”), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria’s common stockholders – diluted, and funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below:

 
Three Months EndedYear Ended
12/31/209/30/206/30/203/31/2012/31/1912/31/2012/31/19
Net income attributable to Alexandria’s common stockholders$435,923 $79,326 $226,600 $16,840 $199,618 $760,791 $350,995 
Depreciation and amortization of real estate assets173,392 173,622 165,040 172,628 137,761 684,682 541,855 
Noncontrolling share of depreciation and amortization from consolidated real estate JVs
(15,032)(15,256)(15,775)(15,870)(10,176)(61,933)(30,960)
Our share of depreciation and amortization from unconsolidated real estate JVs
2,976 2,936 2,858 2,643 2,702 11,413 6,366 
Gain on sales of real estate(152,503)
(1)
(1,586)— — (474)(154,089)(474)
Impairment of real estate – rental properties
25,177 
(1)
7,680 — 7,644 12,334 40,501 
(2)
12,334 
Assumed conversion of 7.00% Series D cumulative convertible preferred stock— — — — — — 3,204 
Allocation to unvested restricted stock awards
(420)(1,261)(2,228)(847)(1,809)(7,018)(5,904)
Funds from operations attributable to Alexandria’s common stockholders – diluted(3)
469,513 245,461 376,495 183,038 339,956 1,274,347 877,416 
Unrealized (gains) losses on non-real estate investments(233,538)14,013 (171,652)17,144 (148,268)(374,033)(161,489)
Impairment of non-real estate investments— — 4,702 19,780 9,991 24,482 17,124 
Impairment of real estate
— — 13,218 2,003 — 15,221 — 
Loss on early extinguishment of debt
7,898 52,770 — — — 60,668 47,570 
Loss on early termination of interest rate hedge agreements
— — — — — — 1,702 
Termination fee— (86,179)— — — (86,179)— 
Acceleration of stock compensation expense due to executive officer resignation— 4,499 — — — 4,499 — 
Preferred stock redemption charge
— — — — — — 2,580 
Removal of assumed conversion of 7.00% Series D cumulative convertible preferred stock— — — — — — (3,204)
Allocation to unvested restricted stock awards
2,774 179 2,251 (591)1,760 4,790 1,307 
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted$246,647 $230,743 $225,014 $221,374 $203,439 $923,795 $783,006 
(1)Refer to “Dispositions” in our Earnings Press Release for additional details.
(2)Includes a $7.6 million impairment of our investment in a recently developed retail property held by our unconsolidated real estate joint venture recognized in 1Q20. This impairment is classified in equity in earnings of unconsolidated real estate joint ventures within our consolidated statements of operations.
(3)Calculated in accordance with standards established by the Nareit Board of Governors. Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in the “Definitions and reconciliations” of our Supplemental Information for additional details.

16

Funds From Operations and Funds From Operations per Share (continued)
q220logo9a.jpg
December 31, 2020
(In thousands, except per share amounts)

The following table presents a reconciliation of net income (loss) per share attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria’s common stockholders – diluted, and funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to rounding.

Three Months EndedYear Ended
12/31/209/30/206/30/203/31/2012/31/1912/31/2012/31/19
Net income per share attributable to Alexandria’s common stockholders – diluted$3.26 $0.63 $1.82 $0.14 $1.74 $6.01 $3.12 
Depreciation and amortization of real estate assets
1.21 1.28 1.22 1.31 1.13 5.01 4.60 
Gain on sales of real estate(1.14)(0.01)— — — (1.22)— 
Impairment of real estate – rental properties0.19 0.06 — 0.06 0.11 0.32 0.11 
Allocation to unvested restricted stock awards
(0.01)(0.01)(0.01)(0.01)(0.02)(0.05)(0.06)
Funds from operations per share attributable to Alexandria’s common stockholders – diluted
3.51 1.95 3.03 1.50 2.96 10.07 7.77 
Unrealized (gains) losses on non-real estate investments(1.75)0.11 (1.38)0.14 (1.29)(2.96)(1.44)
Impairment of non-real estate investments— — 0.04 0.16 0.09 0.19 0.15 
Impairment of real estate— — 0.11 0.02 — 0.12 — 
Loss on early extinguishment of debt
0.06 0.42 — — — 0.48 0.42 
Loss on early termination of interest rate hedge agreements
— — — — — — 0.02 
Termination fee— (0.69)— — — (0.68)— 
Acceleration of stock compensation expense due to executive officer resignation— 0.04 — — — 0.04 — 
Preferred stock redemption charge
— — — — — — 0.02 
Allocation to unvested restricted stock awards
0.02 — 0.01 — 0.01 0.04 0.02 
Funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted
$1.84 $1.83 $1.81 $1.82 $1.77 $7.30 $6.96 
Weighted-average shares of common stock outstanding(1) for calculations of:
Earnings per share – diluted
133,827 125,828 124,448 121,785 114,974 126,490 112,524 
Funds from operations – diluted, per share133,827 125,828 124,448 121,785 114,974 126,490 112,966 
Funds from operations – diluted, as adjusted, per share
133,827 125,828 124,448 121,785 114,974 126,490 112,524 
(1)Refer to “Weighted-average shares of common stock outstanding – diluted” in the “Definitions and reconciliations” of our Supplemental Information for additional details.


17









SUPPLEMENTAL
INFORMATION









q220logo9a.jpg
Company Profile
December 31, 2020
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office REIT, is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million SF. The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

Tenant base

Alexandria is known for our high-quality and diverse tenant base, with 55% of our annual rental revenue generated from tenants that are investment-grade rated or publicly traded large cap companies. The quality, diversity, breadth, and depth of our significant relationships with our tenants provide Alexandria with high-quality and stable cash flows. Alexandria’s underwriting team and long-term industry relationships positively distinguish us from all other publicly traded REITs and real estate companies.

Executive and senior management team

Alexandria’s executive and senior management team has unique experience and expertise in creating, owning, and operating highly dynamic and collaborative campuses in key urban life science, technology, and agtech cluster locations that inspire innovation. From the development of high-quality, sustainable real estate, to the ongoing cultivation of collaborative environments with unique amenities and events, the Alexandria team has a first-in-class reputation of excellence in our niche. Alexandria’s highly experienced management team also includes regional market directors with leading reputations and longstanding relationships within the life science, technology, and agtech communities in their respective urban innovation clusters. We believe that our expertise, experience, reputation, and key relationships in the real estate, life science, technology, and agtech industries provide Alexandria significant competitive advantages in attracting new business opportunities.
Alexandria’s executive and senior management team consists of 47 individuals, averaging 24 years of real estate experience, including 12 years with Alexandria. Our executive management team alone averages 17 years of experience with Alexandria.

EXECUTIVE MANAGEMENT TEAM
Joel S. MarcusStephen A. Richardson
Executive Chairman & FounderCo-Chief Executive Officer
Peter M. MogliaDean A. Shigenaga
Co-Chief Executive Officer &
Co-Chief Investment Officer
President & Chief Financial Officer
Daniel J. RyanLawrence J. Diamond
Co-Chief Investment Officer & Regional Market Director – San DiegoCo-Chief Operating Officer & Regional Market Director – Maryland
Joseph HakmanVincent R. Ciruzzi
Chief Strategic Transactions Officer & Co-Chief Operating OfficerChief Development Officer
Hunter L. KassThomas J. Andrews
Executive Vice President – Regional Market Director – Greater BostonGreater Boston Business Development
John H. CunninghamTerezia C. Nemeth
Executive Vice President – Regional Market Director – New York CityExecutive Vice President – Regional Market Director – San Francisco
Marc E. BindaAndres R. Gavinet
Executive Vice President –
Finance & Treasurer
Chief Accounting Officer
Jackie B. ClemGary D. Dean
General Counsel & SecretaryExecutive Vice President –
Real Estate Legal Affairs
19

q220logo9a.jpg
Investor Information
December 31, 2020
Corporate Headquarters New York Stock Exchange Trading Symbol Information Requests
26 North Euclid Avenue Common stock: ARE Phone:(626) 578-0777
Pasadena, California 91101  Email:[email protected]
   Web:www.are.com
Equity Research Coverage
Alexandria is currently covered by the following research analysts. This list may be incomplete and is subject to change as firms initiate or discontinue coverage of our company. Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, estimates, or forecasts of Alexandria or our management. Alexandria does not by our reference or distribution of the information below imply our endorsement of or concurrence with any opinions, estimates, or forecasts of these analysts. Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports. Several of these firms may, from time to time, own our stock and/or hold other long or short positions in our stock and may provide compensated services to us.

Bank of America Merrill LynchCitigroup Global Markets Inc.JMP SecuritiesRBC Capital Markets
Jamie Feldman / Elvis RodriguezMichael Bilerman / Emmanuel KorchmanAaron Hecht / Matthew HurwitMichael Carroll / Jason Idoine
(646) 855-5808 / (646) 855-1589(212) 816-1383 / (212) 816-1382(415) 835-3963 / (415) 835-3964(440) 715-2649 / (440) 715-2651
Berenberg Capital MarketsEvercore ISIJ.P. Morgan Securities LLCRobert W. Baird & Co. Incorporated
Connor Siversky / Nate CrossettSheila McGrath / Wendy MaAnthony Paolone / Ray ZhongDavid Rodgers / Nicholas Thillman
(646) 949-9037 / (646) 949-9030(212) 497-0882 / (212) 497-0870(212) 622-6682 / (212) 622-5411(216) 737-7341 / (414) 298-5053
BTIG, LLCGreen StreetMizuho Securities USA Inc.SMBC Nikko Securities America, Inc.
Tom Catherwood / James SullivanDaniel Ismail / Dylan BurzinskiOmotayo Okusanya / Venkat KommineniRichard Anderson / Jay Kornreich
(212) 738-6140 / (212) 738-6139(949) 640-8780 / (949) 640-8780(646) 949-9672 / (646) 949-9754(646) 521-2351 / (646) 424-3202
CFRA
Kenneth Leon
(646) 517-2552
Fixed Income CoverageRating Agencies
Barclays Capital Inc.J.P. Morgan Securities LLCMoody’s Investors Service S&P Global Ratings
Srinjoy Banerjee / Devon ZhouMark Streeter / Ian Snyder(212) 553-0376 Fernanda Hernandez / Michael Souers
(212) 526-3521 / (212) 526-6961(212) 834-5086 / (212) 834-3798 (212) 438-1347 / (212) 438-2508
20

Financial and Asset Base Highlights
q220logo9a.jpg
December 31, 2020
(Dollars in thousands, except per share amounts)
 
Three Months Ended (unless stated otherwise)
12/31/209/30/206/30/203/31/2012/31/19
Selected financial data from consolidated financial statements and related information
Rental revenues
$353,950 $438,393 $341,555 $337,942 $308,418 
Tenant recoveries
$107,385 $105,019 $94,301 $99,663 $96,303 
General and administrative expenses$32,690 $36,913 $31,775 $31,963 $29,782 
General and administrative expenses as a percentage of net operating income –
trailing 12 months
9.8%9.9%10.3%10.2%10.0%
Operating margin71%74%72%71%70%
Adjusted EBITDA margin
69%67%69%68%68%
Adjusted EBITDA – quarter annualized
$1,331,608 $1,272,280 $1,253,844 $1,239,016 $1,148,620 
Adjusted EBITDA – trailing 12 months
$1,274,187 $1,228,440 $1,185,347 $1,137,650 $1,085,382 
Net debt at end of period
$7,021,893 $7,396,412 $7,333,905 $6,870,571 $6,582,089 
Net debt and preferred stock to Adjusted EBITDA – quarter annualized5.3x5.8x5.8x5.5x5.7x
Net debt and preferred stock to Adjusted EBITDA – trailing 12 months5.5x6.0x6.2x6.0x6.1x
Fixed-charge coverage ratio – quarter annualized
4.6x4.3x4.2x4.5x4.2x
Fixed-charge coverage ratio – trailing 12 months
4.4x4.3x4.2x4.2x4.2x
Unencumbered net operating income as a percentage of total net operating income
97%96%95%95%95%
Closing stock price at end of period
$178.22 $160.00 $162.25 $137.06 $161.58 
Common shares outstanding (in thousands) at end of period
136,690 133,312 124,559 124,326 120,800 
Total equity capitalization at end of period
$24,360,950 $21,329,886 $20,209,636 $17,040,078 $19,518,915 
Total market capitalization at end of period
$31,924,236 $29,153,057 $27,732,906 $24,345,213 $26,296,394 
Dividend per share – quarter/annualized
$1.09/$4.36$1.06/$4.24$1.06/$4.24$1.03/$4.12$1.03/$4.12
Dividend payout ratio for the quarter
60%61%59%58%61%
Dividend yield – annualized
2.4%2.7%2.6%3.0%2.5%
Amounts related to operating leases:
Operating lease liabilities
$345,750 $326,046 $291,710 $293,173 $271,809 
Rent expense
$5,543 $4,729 $4,936 $4,781 $4,609 
Capitalized interest
$37,589 $32,556 $30,793 $24,680 $23,822 
Weighted-average interest rate for capitalization of interest during the period
3.66%3.64%4.03%3.80%3.88%
21

Financial and Asset Base Highlights (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands, except annual rental revenue per occupied RSF amounts)
 
Three Months Ended (unless stated otherwise)
12/31/209/30/206/30/203/31/2012/31/19
Amounts included in funds from operations and non-revenue-enhancing capital expenditures
Straight-line rent revenue
$23,890 $28,822 $23,367 $20,597 $24,400 
Amortization of acquired below-market leases
$13,514 $13,979 $13,787 $15,964 $8,837 
Straight-line rent expense on ground leases
$348 $229 $167 $171 $219 
Stock compensation expense
$11,394 $12,994 $9,185 $9,929 $10,239 
Amortization of loan fees
$2,905 $2,605 $2,737 $2,247 $2,241 
Amortization of debt premiums
$869 $910 $888 $888 $907 
Non-revenue-enhancing capital expenditures:
Building improvements
$3,466 $3,358 $3,107 $3,198 $3,295 
Tenant improvements and leasing commissions
$31,235 $34,036 $11,500 $12,923 $14,648 
Operating statistics and related information (at end of period)
Number of properties – North America
338 326 304 302 291 
RSF – North America (including development and redevelopment projects under construction)
35,163,572 34,071,653 31,141,758 30,924,356 29,098,433 
Total square feet – North America
49,712,701 47,389,023 43,023,989 41,514,374 39,170,786 
Annual rental revenue per occupied RSF – North America
$49.08 $49.55 $51.30 $51.18 $51.04 
Occupancy of operating properties – North America
94.6%
(1)
94.9%94.8%95.1%96.8%
Occupancy of operating and redevelopment properties – North America
90.0%91.3%92.3%92.9%94.4%
Weighted-average remaining lease term (in years)
7.67.77.87.88.1
Total leasing activity – RSF
1,369,599 1,208,382 1,077,510 703,355 1,752,124 
Lease renewals and re-leasing of space – change in average new rental rates over expiring rates:
Rental rate increases
29.8%39.9%37.2%46.3%37.0%
Rental rate increases (cash basis)10.7%30.9%15.0%22.3%21.7%
RSF (included in total leasing activity above)699,916 605,765 699,130 557,367 571,650 
Same property – percentage change over comparable quarter from prior year:
Net operating income increase2.7%2.9%0.6%2.4%2.0%
Net operating income increase (cash basis)5.0%4.9%2.5%6.1%4.0%
(1)Refer to “Occupancy” in this Supplemental Information for additional details.

22

q220logo9a.jpg
High-Quality, Diverse, and Innovative Tenants
December 31, 2020

Long-Duration Cash Flows From High-Quality, Diverse, and
Innovative Tenants

Investment-Grade or
Publicly Traded Large Cap Tenants
Tenant Mix
q420clienttenantmixv31a.jpg
55%
of ARE’s Annual Rental Revenue(1)
Long-Duration Lease Terms
7.6 Years
Weighted-Average Remaining Term(2)
Percentage of ARE’s Annual Rental Revenue(1)
(1)Represents annual rental revenue in effect as of December 31, 2020.
(2)Based on aggregate annual rental revenue in effect as of December 31, 2020. Refer to “Annual rental revenue” in the “Definitions and reconciliations” of this Supplemental Information for additional details about our methodology on annual rental revenue from unconsolidated real estate joint ventures.
(3)Represents annual rental revenue currently generated from office space that is targeted for a future change in use. The weighted-average remaining term of these leases is 3.3 years.
(4)Represents annual rental revenue from publicly traded tenants with an average daily market capitalization greater than $200 billion for the twelve months ended December 31, 2020.
(5)Our other tenants, aggregating 3.0% of our annual rental revenue, comprise 2.5% of annual rental revenue from technology, professional services, finance, telecommunications, and construction/real estate companies and only 0.5% from retail-related tenants.
23

q220logo9a.jpg
Class A Properties in AAA Locations
December 31, 2020

High-Quality Cash Flows From High Quality Tenants and
Class A Properties in AAA Locations

Industry-Leading
Tenant Roster
AAA Locations
q420realestatev21a.jpg
85%
of ARE’s Top 20
Annual Rental Revenue(1)
From Investment-Grade
or Publicly Traded Large Cap Tenants
Percentage of ARE’s Annual Rental Revenue(1)







(1)Represents annual rental revenue in effect as of December 31, 2020.
24

q220logo9a.jpg
Occupancy
December 31, 2020

Solid Historical Occupancy(1)
Occupancy Across Key Locations(2)
q420occupancysv21a.jpg
96%
Over 10 Years

(1)Represents average occupancy of operating properties in North America as of each December 31 for the last 10 years.
(2)As of December 31, 2020.
(3)Includes 970,199 RSF, or 3.1%, of vacancy in our North America markets, representing lease-up opportunities that will contribute to growth in cash flows at recently acquired properties (noted below). Excluding these acquired vacancies, occupancy of operating properties in North America was 97.7% as of December 31, 2020.
As of December 31, 2020
As of September 30, 2020
Vacant Occupancy ImpactVacantOccupancy Impact
PropertyMarket/SubmarketRSFRegionConsolidatedRSFRegionConsolidated
Alexandria Center® for Life Science – Durham
Research Triangle/Research Triangle251,465 8.9 %0.8 %251,465 8.9 %0.8 %
601, 611, and 651 Gateway BoulevardSan Francisco/South San Francisco199,895 2.7 %0.6 202,871 2.6 %0.7 
SD Tech by AlexandriaSan Diego/Sorrento Mesa71,462 1.1 %0.2 76,639 1.3 %0.2 
5505 Morehouse Drive(1)
San Diego/Sorrento MesaN/AN/AN/A71,021 1.2 %0.2 
Other acquisitionsVarious447,377 
N/A
1.5 257,483 
N/A
0.9 
970,199 3.1 %859,479 2.8 %
(1)We commenced redevelopment of this property during the three months ended December 31, 2020. Refer to “New Class A development and redevelopment properties: current projects” of this Supplemental Information for additional details.
25

q220logo9a.jpg
Key Operating Metrics
December 31, 2020
Historical Same Property
Net Operating Income
Favorable Lease Structure(1)
q420samepropav41a.jpg
q420samepropbv41a.jpg
Strategic Lease Structure by Owner and Operator of Collaborative Life Science, Technology, and Agtech Campuses
Increasing cash flows
Percentage of leases containing
annual rent escalations
94%
Stable cash flows
Percentage of triple
net leases
94%
Lower capex burden
Percentage of leases providing for the
recapture of capital expenditures
93%
Historical Rental Rates:
Renewed/Re-Leased Space
Margins(2)
q420rentalrateav41a.jpg
q420rentalratebv41a.jpg
OperatingAdjusted EBITDA
71%69%
(1)Percentages calculated based on RSF as of December 31, 2020.
(2)Represents percentages for the three months ended December 31, 2020.
26

Same Property Performance
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
December 31, 2020December 31, 2020
Same Property Financial Data
Three Months EndedYear Ended
Same Property Statistical Data
Three Months EndedYear Ended
Percentage change over comparable period from prior year:
Number of same properties
234209
Net operating income increase
2.7%2.6%

Rentable square feet
22,048,30520,707,818
Net operating income increase (cash basis)
5.0%5.1%
Occupancy – current-period average
96.6%96.6%
Operating margin
72%73%
Occupancy – same-period prior-year average
96.4%96.7%

 Three Months Ended December 31,Year Ended December 31,
20202019$ Change% Change20202019$ Change% Change
Income from rentals:
Same properties$279,236 $277,403 $1,833 0.7 %$1,031,126 $1,017,749 $13,377 1.3 %
Non-same properties74,714 31,015 43,699 140.9 440,714 148,039 292,675 197.7 
Rental revenues353,950 308,418 45,532 14.8 1,471,840 1,165,788 306,052 26.3 
Same properties92,018 89,228 2,790 3.1 327,815 313,705 14,110 4.5 
Non-same properties15,367 7,075 8,292 117.2 78,553 37,371 41,182 110.2 
Tenant recoveries107,385 96,303 11,082 11.5 406,368 351,076 55,292 15.7 
Income from rentals461,335 404,721 56,614 14.0 1,878,208 1,516,864 361,344 23.8 
Same properties159 43 116 269.8 368 444 (76)(17.1)
Non-same properties2,226 3,350 (1,124)(33.6)7,061 13,988 (6,927)(49.5)
Other income2,385 3,393 (1,008)(29.7)7,429 14,432 (7,003)(48.5)
Same properties371,413 366,674 4,739 1.3 1,359,309 1,331,898 27,411 2.1 
Non-same properties92,307 41,440 50,867 122.7 526,328 199,398 326,930 164.0 
Total revenues463,720 408,114 55,606 13.6 1,885,637 1,531,296 354,341 23.1 
Same properties103,221 105,580 (2,359)(2.2)373,416 370,926 2,490 0.7 
Non-same properties33,546 16,272 17,274 106.2 156,808 74,566 82,242 110.3 
Rental operations136,767 121,852 14,915 12.2 530,224 445,492 84,732 19.0 
Same properties268,192 261,094 7,098 2.7 985,893 960,972 24,921 2.6 
Non-same properties58,761 25,168 33,593 133.5 369,520 124,832 244,688 196.0 
Net operating income$326,953 $286,262 $40,691 14.2 %$1,355,413 $1,085,804 $269,609 24.8 %
Net operating income – same properties
$268,192 $261,094 $7,098 2.7 %$985,893 $960,972 $24,921 2.6 %
Straight-line rent revenue (16,528)(20,174)3,646 (18.1)(67,243)(84,167)16,924 (20.1)
Amortization of acquired below-market leases(3,192)(4,265)1,073 (25.2)(10,791)(13,372)2,581 (19.3)
Net operating income – same properties (cash basis)
$248,472 $236,655 $11,817 5.0 %$907,859 $863,433 $44,426 5.1 %

Refer to “Same property comparisons” in the “Definitions and reconciliations” of this Supplemental Information for a reconciliation of same properties to total properties. “Definitions and reconciliations” also contains definitions of “Tenant recoveries” and “Net operating income” and their respective reconciliations from the most directly comparable financial measures presented in accordance with GAAP.

27

Leasing Activity
q220logo9a.jpg
December 31, 2020
(Dollars per RSF)
Three Months EndedYear EndedYear Ended
December 31, 2020December 31, 2020December 31, 2019
Including
Straight-Line Rent
Cash BasisIncluding
Straight-Line Rent
Cash BasisIncluding
Straight-Line Rent
Cash Basis
Leasing activity:
Renewed/re-leased space(1)
  
Rental rate changes
29.8%10.7%37.6%
(2)
18.3%
(2)
32.2%17.6%
New rates
$48.99 $46.02 $49.51 $46.53 $58.65 $56.19 
Expiring rates
$37.73 $41.57 $35.99 $39.32 $44.35 $47.79 
RSF
699,916 2,556,833 
(2)
2,427,108 
Tenant improvements/leasing commissions
$36.10 $35.08 $20.28 
Weighted-average lease term
7.5 years6.0 years5.7 years
Developed/redeveloped/previously vacant space leased
New rates
$60.23 $55.74 $56.67 $53.61 $55.95 $52.19 
RSF
669,683 1,802,013 2,635,614 
Tenant improvements/leasing commissions
$40.60 

$28.17 $13.74 
Weighted-average lease term
9.7 years9.0 years9.8 years
Leasing activity summary (totals):
New rates
$54.49 $50.77 $52.47 $49.46 $57.25 $54.11 
RSF
1,369,599 4,358,846 
(3)
5,062,722 
Tenant improvements/leasing commissions
$38.30 $32.22 $16.88 
Weighted-average lease term
8.6 years7.3 years7.8 years
Lease expirations(1)
Expiring rates
$37.34 $40.64 $36.03 $39.01 $43.43 $46.59 
RSF
878,112 3,560,188 2,822,434 


Leasing activity includes 100% of results for each property in which we have an investment in North America.

(1)Excludes month-to-month leases aggregating 96,383 RSF and 41,809 RSF as of December 31, 2020 and 2019, respectively.
(2)Represents our highest annual rental rate increases and RSF leasing activity for renewed and re-leased space in the past 10 years.
(3)During the year ended December 31, 2020, we granted tenant concessions/free rent averaging 2.1 months with respect to the 4,358,846 RSF leased. Approximately 59% of the leases executed during the year ended December 31, 2020, did not include concessions for free rent.
28

q220logo9a.jpg
Contractual Lease Expirations
December 31, 2020
YearRSFPercentage of
Occupied RSF
Annual Rental Revenue (Per RSF)(1)
Percentage of Total
Annual Rental Revenue
2021
(2)
1,880,366 6.3 %$40.75 5.3 %
20222,512,016 8.4 %$45.95 7.9 %
20233,387,053 11.3 %$41.50 9.6 %
20242,273,200 7.6 %$45.03 7.0 %
20252,366,093 7.9 %$46.79 7.6 %
20261,725,242 5.8 %$47.71 5.6 %
20272,071,365 6.9 %$52.36 7.4 %
20282,449,460 8.2 %$49.28 8.3 %
20291,829,233 6.1 %$55.68 7.0 %
20302,074,876 6.9 %$52.67 7.5 %
Thereafter7,386,330 24.6 %$52.73 26.8 %

Market
2021 Contractual Lease Expirations (in RSF)
Annual Rental Revenue
(Per RSF)(1)
2022 Contractual Lease Expirations (in RSF)
Annual Rental Revenue
(Per RSF)(1)
LeasedNegotiating/
Anticipating
Targeted for
Development/
Redevelopment(3)
Remaining
Expiring
Leases(4)
Total(2)
LeasedNegotiating/
Anticipating
Targeted for
Development/
Redevelopment(3)
Remaining
Expiring Leases(5)
Total
Greater Boston60,186 80,265 266,484 228,358 635,293 $44.31 — 

7,072 — 

568,831 
(6)
575,903 $58.15 
San Francisco37,839 233,606 26,738 212,785 510,968 45.76 — 10,011 490,127 

277,836 777,974 49.56 
New York City— 7,924 — 2,007 9,931 N/A18,120 27,179 — 2,979 48,278 N/A
San Diego101,437 89,576 41,475 213,047 

445,535 31.73 83,104 — 

231,585 243,454 558,143 38.55 
Seattle— 15,184 — 20,974 36,158 49.69 — — 51,255 125,462 176,717 36.36 
Maryland33,000 — — 29,865 62,865 23.38 — — — 

74,817 74,817 29.40 
Research Triangle16,942 — — 90,364 107,306 31.37 — — — 221,937 221,937 21.77 
Canada— — — 13,672 13,672 23.71 — — — 28,664 28,664 20.97 
Non-cluster/other markets— — — 58,638 58,638 44.70 — — — 49,583 49,583 55.84 
Total249,404 426,555 334,697 869,710 1,880,366 $40.75 101,224 44,262 772,967 1,593,563 

2,512,016 $45.95 
Percentage of expiring leases
13 %23 %18 %46 %100 %4 %2 %31 %63 %100 %

(1)Represents amounts in effect as of December 31, 2020.
(2)Excludes month-to-month leases aggregating 96,383 RSF as of December 31, 2020.
(3)Represents RSF targeted for development or redevelopment upon expiration of existing in-place leases, primarily related to recently acquired properties. Refer to "Definitions and reconciliations" of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
(4)The largest remaining contractual lease expirations are three leases ranging from 35,000 RSF to 45,000 RSF.
(5)The largest remaining contractual lease expiration includes a Class A office/laboratory buildings aggregating 113,555 RSF in our Cambridge/Inner Suburbs submarket and four other leases ranging from 50,000 RSF to 60,000 RSF.
(6)68% of the remaining expiring leases in Greater Boston are located in our Cambridge/Inner Suburbs submarket.

29

Top 20 Tenants
q220logo9a.jpg
December 31, 2020
(Dollars in thousands, except average market cap amounts)
85% of Top 20 Annual Rental Revenue From Investment-Grade
or Publicly Traded Large Cap Tenants(1)

Tenant
Remaining Lease Term(1) (in years)
Aggregate
RSF
Annual Rental Revenue(1)
Percentage of Aggregate Annual Rental Revenue(1)
Investment-Grade
Credit Ratings
Average Market Cap(1)
(in billions)
Moody’sS&P
1Bristol-Myers Squibb Company7.7 896,867 $52,460 3.7 %A2A+$137.9 
2Takeda Pharmaceutical Company Ltd.8.6 606,249 39,342 2.8 Baa2BBB+$56.7 
3Facebook, Inc.11.0 903,786 38,899 2.7 ——$668.4 
4Illumina, Inc.9.6 891,495 35,907 2.5 —BBB$47.7 
5Sanofi7.5 494,693 33,868 2.4 A1AA$124.0 
6Eli Lilly and Company8.5 531,784 33,527 2.3 A2A+$142.4 
7Moderna, Inc.11.4 615,458 32,147 2.2 ——$24.1 
8Novartis AG7.6 423,914 30,101 2.1 A1AA-$217.7 
9Uber Technologies, Inc.61.9 
(2)
1,009,188 27,379 1.9 ——$62.3 
10Roche2.7 
(3)
649,482 24,129 1.7 Aa3AA$295.3 
11bluebird bio, Inc.6.4 312,805 23,142 1.6 ——$3.7 
12Maxar Technologies4.5 478,000 21,577 1.5 ——$1.2 
13Massachusetts Institute of Technology8.0 257,626 21,145 1.5 AaaAAA$— 
14Jazz Pharmaceuticals, Inc.9.7 198,041 20,003 1.4 ——$7.2 
15New York University10.7 204,691 19,531 1.4 Aa2AA-$— 
16Merck & Co., Inc.13.4 311,015 19,392 1.4 A1AA-$204.9 
17Pfizer Inc.4.2 416,979 17,762 1.2 A2A+$203.2 
18Amgen Inc.3.3 407,369 16,838 1.2 Baa1A-$135.9 
19United States Government6.8 284,777 16,601 1.2 AaaAA+$— 
20athenahealth, Inc.12.4 333,956 15,413 1.1 ——$— 
Total/weighted-average
11.0 
(2)
10,228,175 $539,163 37.8 %

(1)Based on aggregate annual rental revenue in effect as of December 31, 2020. Refer to “Annual rental revenue” and “Investment-grade or publicly traded large cap tenants” in the “Definitions and reconciliations” of this Supplemental Information for additional details about our methodology on annual rental revenue from unconsolidated real estate joint ventures and average daily market capitalization.
(2)Includes (i) ground leases for land at 1455 and 1515 Third Street (two buildings aggregating 422,980 RSF) and (ii) leases at 1655 and 1725 Third Street (two buildings aggregating 586,208 RSF) owned by our unconsolidated joint venture in which we have an ownership interest of 10%. Annual rental revenue is presented using 100% of the annual rental revenue of our consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Refer to footnote 1 for additional details. Excluding the ground lease, the weighted-average remaining lease term for our top 20 tenants was 8.4 years as of December 31, 2020.
(3)Includes 197,787 RSF expiring in 2022 at our recently acquired property at 651 Gateway Boulevard in our South San Francisco submarket. Upon expiration of the lease, 651 Gateway Boulevard will be redeveloped into a Class A office/laboratory building. Excluding this 197,787 RSF, the weighted-average remaining term of space occupied by Roche is 3.1 years.
30

Summary of Properties and Occupancy
q220logo9a.jpg
December 31, 2020
(Dollars in thousands, except per RSF amounts)
Summary of properties
Market
RSFNumber of PropertiesAnnual Rental Revenue
OperatingDevelopmentRedevelopmentTotal% of TotalTotal% of TotalPer RSF
Greater Boston
8,454,396 — 296,489 8,750,885 25 %72 $507,459 36 %$61.20 
San Francisco7,495,390 744,715 92,147 8,332,252 24 61 362,262 25 57.87 
New York City
1,145,296 — 122,382 1,267,678 3 5 81,185 6 73.68 
San Diego
6,367,526 146,456 79,945 6,593,927 19 80 233,128 16 39.14 
Seattle
1,747,332 100,086 213,976 2,061,394 6 22 81,477 6 48.59 
Maryland
2,821,574 261,096 169,420 3,252,090 9 44 80,429 6 29.97 
Research Triangle
2,810,670 410,000 652,381 3,873,051 11 35 61,354 4 24.38 
Canada
256,967 — — 256,967 1 3 4,870 — 23.16 
Non-cluster/other markets549,479 — — 549,479 1 12 10,608 1 36.64 
Properties held for sale
225,849 — — 225,849 1 4 6,257 — N/A
North America
31,874,479 1,662,353 1,626,740 35,163,572 100 %338 $1,429,029 100 %$49.08 
3,289,093

Summary of occupancy
 Operating PropertiesOperating and Redevelopment Properties
Market12/31/209/30/2012/31/1912/31/209/30/2012/31/19
Greater Boston98.1 %98.3 %99.1 %94.8 %95.0 %97.1 %
San Francisco95.8 
(1)
95.3 98.3 94.7 94.2 93.6 
New York City97.3 95.5 99.2 87.8 84.8 88.1 
San Diego93.5 
(1)
93.7 92.3 92.4 92.7 92.3 
Seattle96.0 91.0 98.7 85.5 91.0 98.7 
Maryland96.1 96.0 96.7 90.6 96.0 95.2 
Research Triangle89.6 
(1)
90.5 96.5 72.7 73.4 96.5 
Subtotal95.5 95.2 97.0 90.7 91.5 94.6 
Canada81.8 90.0 93.7 81.8 90.0 93.7 
Non-cluster/other markets52.7 69.8 80.1 52.7 69.8 80.1 
North America94.6 %
(1)
94.9 %96.8 %90.0 %91.3 %94.4 %
(1)Refer to “Occupancy” in this Supplemental Information for additional details on vacancy at acquired properties.

Refer to “Definitions and reconciliations” in this Supplemental Information for additional details.

31

Property Listing
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
Greater Boston
Cambridge/Inner Suburbs
Alexandria Center® at Kendall Square
2,365,487 — — 2,365,487 10$168,794 98.9 %98.9 %
50, 60, 75/125(1), 100, and 225(1) Binney Street, 161 and 215 First Street, 150 Second Street, 300 Third Street, and 11 Hurley Street
Alexandria Technology Square®
1,181,635 — — 1,181,635 7101,943 99.7 99.7 
100, 200, 300, 400, 500, 600, and 700 Technology Square
The Arsenal on the Charles
539,799 — 296,489 836,288 1121,914 100.0 64.5 
  311, 321, and 343 Arsenal Street, 300 and 400 North Beacon Street,
1, 2, and 3 Kingsbury Avenue, and 100, 200, and 400 Talcott Avenue
Alexandria Center® at One Kendall Square
815,156 — — 815,156 1067,853 96.8 96.8 
One Kendall Square – Buildings 100, 200, 300, 400, 500, 600/700, 1400, 1800, 2000, and 399 Binney Street
480 and 500 Arsenal Street
234,260 — — 234,260 29,769 86.6 86.6 
640 Memorial Drive
225,504 — — 225,504 113,860 100.0 100.0 
780 and 790 Memorial Drive
99,658 — — 99,658 28,292 100.0 100.0 
167 Sidney Street and 99 Erie Street
54,549 — — 54,549 24,025 100.0 100.0 
79/96 13th Street (Charlestown Navy Yard)
25,309 — — 25,309 1620 100.0 100.0 
Cambridge/Inner Suburbs
5,541,357 — 296,489 5,837,846 46397,070 98.4 93.4 
Seaport Innovation District
380 and 420 E Street195,506 — — 195,506 23,522 100.0 100.0 
5 Necco Street
87,163 — — 87,163 14,672 86.6 86.6 
Seaport Innovation District282,669 — — 282,669 38,194 95.9 95.9 
Route 128
Reservoir Woods515,273 — — 515,273 322,004 100.0 100.0 
40, 50, and 60 Sylvan Road
275 Grove Street
509,702 — — 509,702 122,577 87.4 87.4 
One Upland Road and 100 Tech Drive443,513 — — 443,513 218,008 100.0 100.0 
Alexandria Park at 128
343,882 — — 343,882 812,544 100.0 100.0 
3 and 6/8 Preston Court, 29, 35, and 44 Hartwell Avenue, 35 and 45/47 Wiggins Avenue, and 60 Westview Street
225, 266, and 275 Second Avenue
317,617 — — 317,617 314,073 100.0 100.0 
19 Presidential Way
144,892 — — 144,892 15,174 99.8 99.8 
100 Beaver Street
82,330 — — 82,330 14,254 100.0 100.0 
285 Bear Hill Road
26,270 — — 26,270 11,167 100.0 100.0 
Route 128
2,383,479 — — 2,383,479 2099,801 97.3 97.3 
Route 495
111 and 130 Forbes Boulevard
155,846 — — 155,846 21,745 100.0 100.0 
20 Walkup Drive
91,045 — — 91,045 1649 100.0 100.0 
Route 495
246,891 — — 246,891 32,394 100.0 100.0 
Greater Boston
8,454,396 — 296,489 8,750,885 72$507,459 98.1 %94.8 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.
32

Property Listing (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
San Francisco
Mission Bay
Alexandria Center® for Science and Technology – Mission Bay
1,990,262 — — 1,990,262 9$90,364 99.9 %99.9 %
1455, 1515, 1655(1), and 1725(1) Third Street, 409 and 499 Illinois Street(1), 1500(1) and 1700 Owens Street, and 455 Mission Bay Boulevard South
Mission Bay1,990,262 — — 1,990,262 990,364 99.9 99.9 
South San Francisco
Alexandria Technology Center® – Gateway
1,412,480 — — 1,412,480 1154,517 81.5 81.5 
600, 601(1), 611(1), 630, 650, 651(1), 681(1), 685(1), 701(1), 901, and 951 Gateway Boulevard
213, 249, 259, 269, and 279 East Grand Avenue
919,704 — — 919,704 548,744 100.0 100.0 
201 Haskins Way
— 315,000 — 315,000 1— N/AN/A
400 and 450 East Jamie Court
163,035 — — 163,035 29,549 100.0 100.0 
500 Forbes Boulevard(1)
155,685 — — 155,685 16,619 100.0 100.0 
7000 Shoreline Court
136,395 — — 136,395 18,547 99.4 99.4 
341 and 343 Oyster Point Boulevard
107,960 — — 107,960 25,767 100.0 100.0 
849/863 Mitten Road/866 Malcolm Road
103,857 — — 103,857 15,086 100.0 100.0 
South San Francisco2,999,116 315,000 — 3,314,116 24138,829 91.3 91.3 
Greater Stanford
Menlo Gateway(1)
772,983 — — 772,983 329,790 100.0 100.0 
100 Independence Drive and 125 and 135 Constitution Drive
Alexandria Center® for Life Science – San Carlos
233,201 429,715 — 662,916 510,853 100.0 100.0 
825, 835, and 960 Industrial Road and 987 and 1075 Commercial Street
3825 and 3875 Fabian Way
478,000 — — 478,000 221,577 100.0 100.0 
Alexandria Stanford Life Science District
289,685 — 92,147 381,832 423,888 100.0 75.9 
3160, 3165, 3170, and 3181 Porter Drive
Alexandria PARC
197,498 — — 197,498 410,164 85.9 85.9 
2100, 2200, 2300, and 2400 Geng Road
3330, 3412, 3450, and 3460 Hillview Avenue183,267 — — 183,267 415,180 100.0 100.0 
2425 Garcia Avenue/2400/2450 Bayshore Parkway
99,208 — — 99,208 14,257 100.0 100.0 
Shoreway Science Center
82,462 — — 82,462 25,340 100.0 100.0 
75 and 125 Shoreway Road
1450 Page Mill Road
77,634 — — 77,634 18,009 100.0 100.0 
3350 West Bayshore Road
60,000 — — 60,000 12,191 62.3 62.3 
2625/2627/2631 Hanover Street
32,074 — — 32,074 11,820 100.0 100.0 
Greater Stanford2,506,012 429,715 92,147 3,027,874 28133,069 98.0 94.5 
San Francisco7,495,390 744,715 92,147 8,332,252 61$362,262 95.8 %94.7 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.
33

Property Listing (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
New York City
New York City
Alexandria Center® for Life Science – New York City
740,972 — — 740,972 3$64,994 95.9 %95.9 %
430 and 450 East 29th Street
219 East 42nd Street
349,947 — — 349,947 114,006 100.0 100.0 
Alexandria Center® – Long Island City
54,377 — 122,382 176,759 12,185 100.0 30.8 
30-02 48th Avenue
New York City
1,145,296 — 122,382 1,267,678 581,185 97.3 87.8 
San Diego
Torrey Pines
ARE Spectrum
336,461 146,456 — 482,917 418,072 100.0 100.0 
3115 and 3215 Merryfield Row and 3013 and 3033 Science Park Road
ARE Torrey Ridge
294,326 — — 294,326 310,297 72.1 72.1 
10578, 10618, and 10628 Science Center Drive
ARE Sunrise
236,635 — — 236,635 38,238 100.0 100.0 
10931/10933 and 10975 North Torrey Pines Road, 3010 Science Park Road, and 10996 Torreyana Road
ARE Nautilus
220,651 — — 220,651 410,924 100.0 100.0 
3530 and 3550 John Hopkins Court and 3535 and 3565 General Atomics Court
11119, 11255, and 11355 North Torrey Pines Road
211,641 — — 211,641 38,738 100.0 100.0 
3545 Cray Court
118,225 — — 118,225 1— — — 
Torrey Pines1,417,939 146,456 — 1,564,395 1856,269 85.9 85.9 
University Town Center
Alexandria Point(1)
1,435,916 — — 1,435,916 861,391 99.1 99.1 
9880(2), 10210, 10260, 10290, and 10300 Campus Point Drive and 4161, 4224, and 4242 Campus Point Court
5200 Illumina Way(1)
792,687 — — 792,687 629,977 100.0 100.0 
University District
535,459 — — 535,459 819,979 100.0 100.0 
9363, 9393, and 9625(1) Towne Centre Drive, 4755, 4757, and 4767 Nexus Center Drive, and 4555 and 4796 Executive Drive
University Town Center2,764,062 — — 2,764,062 22$111,347 99.5 %99.5 %

(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.
(2)We own 100% of this property.
34

Property Listing (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
San Diego (continued)
Sorrento Mesa
SD Tech by Alexandria(1)
779,989 — 79,945 859,934 13$24,130 87.3 %79.2 %
9605, 9645, 9675, 9685, 9725, 9735, 9808, 9855, and 9868 Scranton Road, 5505 Morehouse Drive(2), and 10065, 10121(2), and 10151(2) Barnes Canyon Road
6420 and 6450 Sequence Drive318,200 — — 318,200 28,069 89.5 89.5 
Summers Ridge Science Park
316,531 — — 316,531 411,077 100.0 100.0 
9965, 9975, 9985, and 9995 Summers Ridge Road
ARE Portola
101,857 — — 101,857 33,603 100.0 100.0 
6175, 6225, and 6275 Nancy Ridge Drive
5810/5820 Nancy Ridge Drive
82,272 — — 82,272 1855 41.4 41.4 
7330 Carroll Road
66,244 — — 66,244 12,431 100.0 100.0 
9877 Waples Street63,774 — — 63,774 12,364 100.0100.0 
5871 Oberlin Drive
33,817 — — 33,817 1892 50.2 50.2 
Sorrento Mesa1,762,684 — 79,945 1,842,629 2653,421 88.8 84.9 
Sorrento Valley
3911, 3931, 3985, 4025, 4031, 4045, and 4075 Sorrento Valley Boulevard
191,406 — — 191,406 75,691 100.0 100.0 
11025, 11035, 11045, 11055, 11065, and 11075 Roselle Street
121,655 — — 121,655 63,428 100.0 100.0 
Sorrento Valley313,061 — — 313,061 139,119 100.0 100.0 
I-15 Corridor
13112 Evening Creek Drive
109,780 — — 109,780 12,972 100.0 100.0 
San Diego
6,367,526 146,456 79,945 6,593,927 80233,128 93.5 92.4 
Seattle
Lake Union
The Eastlake Life Science Campus by Alexandria837,204 100,086 — 937,290 846,609 97.6 97.6 
1165, 1201(1), 1208(1), 1616 and 1551 Eastlake Avenue East, 188 and 199(1) East Blaine Street, and 1600 Fairview Avenue East
400 Dexter Avenue North
290,111 — — 290,111 114,820 100.0 100.0 
2301 5th Avenue
197,135 — — 197,135 19,308 99.0 99.0 
219 Terry Avenue North
30,705 — — 30,705 11,852 100.0 100.0 
601 Dexter Avenue North
18,680 — — 18,680 1425 100.0 100.0 
Lake Union1,373,835 100,086 — 1,473,921 12$73,014 98.4 %98.4 %

(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.
(2)We own 100% of this property.
35

Property Listing (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
Seattle (continued)
SoDo
830 4th Avenue South42,380 — — 42,380 1$1,479 70.5 %70.5 %
Elliott Bay
3000/3018 Western Avenue
47,746 — — 47,746 11,839 100.0 100.0 
410 West Harrison Street and 410 Elliott Avenue West
36,724 — — 36,724 2415 36.4 36.4 
Elliott Bay84,470 — — 84,470 32,254 72.4 72.4 
Other246,647 — 213,976 460,623 64,730 94.9 50.8 
Seattle
1,747,332 100,086 213,976 2,061,394 2281,477 96.0 85.5 
Maryland
Rockville
9800, 9804, 9900, 9920, and 9950 Medical Center Drive
383,956 261,096 — 645,052 814,944 93.1 93.1 
9704, 9708, 9712, and 9714 Medical Center Drive
215,619 — — 215,619 47,926 100.0 100.0 
1330 Piccard Drive
131,511 — — 131,511 13,810 100.0 100.0 
9605 Medical Center Drive
115,691 — — 115,691 13,100 83.1 83.1 
1500 and 1550 East Gude Drive
90,489 — — 90,489 21,411 77.3 77.3 
14920 and 15010 Broschart Road
86,703 — — 86,703 22,283 100.0 100.0 
1405 Research Boulevard
72,170 — — 72,170 12,476 100.0 100.0 
5 Research Place
63,852 — — 63,852 12,743 100.0 100.0 
5 Research Court
51,520 — — 51,520 11,788 100.0 100.0 
9920 Belward Campus Drive
51,181 — — 51,181 11,687 100.0 100.0 
12301 Parklawn Drive
49,185 — — 49,185 11,329 100.0 100.0 
Rockville1,311,877 261,096 — 1,572,973 2343,497 94.9 94.9 
Gaithersburg
Alexandria Technology Center® – Gaithersburg I
613,438 — — 613,438 916,177 96.3 96.3 
9, 25, 35, 45, 50, and 55 West Watkins Mill Road and 910, 930, and 940 Clopper Road
Alexandria Technology Center® – Gaithersburg II
315,085 — 169,420 484,505 77,966 94.3 61.3 
700, 704(1), and 708 Quince Orchard Road and 19, 20, 21, and 22 Firstfield Road
401 Professional Drive
63,154 — — 63,154 11,833 100.0 100.0 
950 Wind River Lane
50,000 — — 50,000 11,004 100.0 100.0 
620 Professional Drive
27,950 — — 27,950 11,207 100.0 100.0 
Gaithersburg1,069,627 — 169,420 1,239,047 1928,187 96.2 83.0 
Beltsville
8000/9000/10000 Virginia Manor Road 191,884 — — 191,884 12,618 98.4 98.4 
Northern Virginia
14225 Newbrook Drive248,186 — — 248,186 16,127 100.0 100.0 
Maryland
2,821,574 261,096 169,420 3,252,090 44$80,429 96.1 %90.6 %
(1)We own a partial interest in this property through a real estate joint venture. Refer to “Joint venture financial information” of this Supplemental Information for additional details.
36

Property Listing (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Market / Submarket / Address
RSF
Number of PropertiesAnnual Rental Revenue
Occupancy Percentage
OperatingOperating and Redevelopment
OperatingDevelopmentRedevelopmentTotal
Research Triangle
Research Triangle
Alexandria Center® for Life Science – Durham
1,585,766 — 652,381 2,238,147 16$26,261 84.1 %59.6 %
6, 8, 10, 12, 14, 40, 41, 42, and 65 Moore Drive, 21, 25, 27, 29, and 31 Parmer Way, 2400 Ellis Road, and 14 TW Alexander Drive
Alexandria Center® for Advanced Technologies
100,000 250,000 — 350,000 32,296 99.0 99.0 
6, 8, and 10 Davis Drive
Alexandria Center® for AgTech
180,400 160,000 — 340,400 26,488 95.2 95.2 
5 and 9 Laboratory Drive
Alexandria Technology Center® – Alston
186,870 — — 186,870 33,951 94.7 94.7 
100, 800, and 801 Capitola Drive
108/110/112/114 TW Alexander Drive
158,417 — — 158,417 14,624 85.8 85.8 
Alexandria Innovation Center® – Research Triangle
136,455 — — 136,455 34,108 100.0 100.0 
7010, 7020, and 7030 Kit Creek Road
7 Triangle Drive
96,626 — — 96,626 13,156 100.0 100.0 
2525 East NC Highway 54
82,996 — — 82,996 13,651 100.0 100.0 
407 Davis Drive
81,956 — — 81,956 11,644 100.0 100.0 
601 Keystone Park Drive
77,395 — — 77,395 11,375 100.0 100.0 
6040 George Watts Hill Drive
61,547 — — 61,547 12,148 100.0 100.0 
5 Triangle Drive
32,120 — — 32,120 11,112 100.0 100.0 
6101 Quadrangle Drive
30,122 — — 30,122 1540 100.0 100.0 
Research Triangle
2,810,670 410,000 652,381 3,873,051 3561,354 89.6 72.7 
Canada
256,967 — — 256,967 34,870 81.8 81.8 
Non-cluster/other markets549,479 — — 549,479 1210,608 52.7 52.7 
North America, excluding properties held for sale
31,648,630 1,662,353 1,626,740 34,937,723 3341,422,772 94.6 %90.0 %
Properties held for sale
225,849 — — 225,849 46,257 51.1 %51.1 %
Total – North America
31,874,479 1,662,353 1,626,740 35,163,572 338$1,429,029 
37

Investments in Real Estate
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)


As of February 1, 2021, construction activities were in process at all of our active construction projects. Construction workers continue to observe social distancing and follow rules that restrict gatherings of large groups of people in close proximity, as well as adhere to other appropriate measures, which may slow the pace of construction.


Development and Redevelopment
OperatingUnder ConstructionNear
Term
Intermediate
Term
FutureSubtotalTotal
Investments in real estate
Book value as of December 31, 2020(1)
$17,423,908 $1,667,842 $955,207 $452,404 $738,994 $3,814,447 $21,238,355 
Square footage
Operating31,874,479 — — — — — 31,874,479 
New Class A development and redevelopment properties— 3,289,093 4,931,216 3,521,115 9,208,795 20,950,219 20,950,219 
Value-creation square feet currently included in rental properties(2)
— — (617,749)(684,030)(1,810,218)(3,111,997)(3,111,997)
Total square footage
31,874,479 3,289,093 4,313,467 2,837,085 7,398,577 17,838,222 49,712,701 


(1)Balances exclude our share of the cost basis associated with our properties held by our unconsolidated real estate joint ventures, which is classified as investments in unconsolidated real estate joint ventures in our consolidated balance sheets. Refer to “Investments in real estate” in the “Definitions and reconciliations” of this Supplemental Information for reconciliation detail of investments in real estate.
(2)Refer to “Investments in real estate” in the “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
38

New Class A Development and Redevelopment Properties: Recent Deliveries
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)
Alexandria Center® for Life Science –
San Carlos
Alexandria Center® –
Long Island City
9877 Waples Street
San Francisco/Greater Stanford New York City/New York CitySan Diego/Sorrento Mesa
96,463 RSF17,716 RSF63,744 RSF
q420industrialroadv12a.jpg
q420binderyv12a.jpg
q420waples9877v11a.jpg
Property/Market/SubmarketOur Ownership InterestDev/RedevRSF Placed in Service in 4Q20
Occupancy Percentage(1)
Total ProjectUnlevered Yields
Delivery DateInitial StabilizedInitial Stabilized (Cash Basis)
RSFInvestment
Alexandria Center® for Life Science – San Carlos/San Francisco/Greater Stanford
December 2020100%Dev96,463 100%526,178 $630,000 6.4 %6.1 %
Alexandria Center® – Long Island City/New York City/New York City
December 2020100%Redev17,716 100%176,759 $184,300 5.5 %5.6 %
9877 Waples Street/San Diego/Sorrento MesaDecember 2020100%Redev63,774 100%63,744 $31,000 8.8 %8.1 %
Total177,953 

(1)    Relates to total operating RSF placed in service as of the most recent delivery.



Refer to “New Class A development and redevelopment properties: current projects” of this Supplemental Information for information on the RSF in service and under construction, if applicable.

39

New Class A Development and Redevelopment Properties: Current Projects
q220logo9a.jpg
December 31, 2020

The Arsenal on the Charles201 Haskins Way
Alexandria Center® for Life Science –
San Carlos
Greater Boston/
Cambridge/Inner Suburbs
San Francisco/South San FranciscoSan Francisco/Greater Stanford
296,489 RSF315,000 RSF429,715 RSF
q420arsenalv21a.jpg
q420haskinswayv11.jpg
q420industrialroadv12a.jpg

3160 Porter Drive
Alexandria Center® –
Long Island City
3115 Merryfield Row5505 Morehouse Drive
San Francisco/Greater StanfordNew York City/New York CitySan Diego/Torrey PinesSan Diego/Sorrento Mesa
92,147 RSF122,382 RSF146,456 RSF79,945 RSF
q420porterdrivev11a.jpg
q420binderyv12a.jpg
q420merryfield31151a.jpg
q420morehouse1a.jpg
40

New Class A Development and Redevelopment Properties: Current Projects (continued)
q220logo9a.jpg
December 31, 2020
1165 Eastlake Avenue East9804 Medical Center Drive9950 Medical Center Drive
Seattle/Lake UnionMaryland/RockvilleMaryland/Rockville
100,086 RSF176,832 RSF84,264 RSF
q420eastlake1165v11a.jpg
q420medical9804v11.jpg
q420medical9950v11.jpg
700 Quince Orchard Road
Alexandria Center® for Life Science – Durham(1)
Alexandria Center® for AgTech
Alexandria Center® for
Advanced Technologies
Maryland/GaithersburgResearch Triangle/Research TriangleResearch Triangle/Research TriangleResearch Triangle/Research Triangle
169,420 RSF652,381 RSF160,000 RSF250,000 RSF
q420quince7001a.jpg
q420durham1a.jpg
q420lab9v11a.jpg
q420davis8v11a.jpg


(1)     Represents 2400 Ellis Road in our Alexandria Center® for Life Science – Durham campus.


41

New Class A Development and Redevelopment Properties: Current Projects (continued)
q220logo9a.jpg
December 31, 2020
Property/Market/SubmarketSquare FootagePercentage
Dev/RedevIn ServiceCIPTotalLeasedLeased/Negotiating
Initial
Occupancy(1)
Under construction
The Arsenal on the Charles/Greater Boston/Cambridge/Inner SuburbsRedev539,799 296,489 836,288 86 %92 %2021
201 Haskins Way/San Francisco/South San FranciscoDev— 315,000 315,000 100 100 2Q21
Alexandria Center® for Life Science – San Carlos/San Francisco/Greater Stanford
Dev96,463 429,715 526,178 89 100 4Q20
3160 Porter Drive/San Francisco/Greater StanfordRedev— 92,147 92,147 20 20 1H21
Alexandria Center® – Long Island City/New York City/New York City
Redev54,377 122,382 176,759 31 31 4Q20
3115 Merryfield Row/San Diego/Torrey PinesDev— 146,456 146,456 80 87 2022
5505 Morehouse Drive/San Diego/Sorrento MesaRedev— 79,945 79,945 35 35 2021
1165 Eastlake Avenue East/Seattle/Lake UnionDev— 100,086 100,086 100 100 2Q21
Other/SeattleRedev246,647 213,976 460,623 51 51 2022
9804 Medical Center Drive/Maryland/RockvilleDev— 176,832 176,832 100 100 1Q21
9950 Medical Center Drive/Maryland/RockvilleDev— 84,264 84,264 100 100 2021
700 Quince Orchard Road/Maryland/GaithersburgRedev— 169,420 169,420 100 100 2021
Alexandria Center® for Life Science – Durham/Research Triangle/
   Research Triangle(2)
Redev— 652,381 652,381 77 77 1H21/2022
Alexandria Center® for AgTech/Research Triangle/Research Triangle(3)
Redev/Dev180,400 160,000 340,400 55 55 2021
Alexandria Center® for Advanced Technologies/Research Triangle/
   Research Triangle
Dev— 250,000 250,000 
(4)
40 
(4)
55 
(4)
2H21/2022
1,117,686 3,289,093 4,406,779 74 78 
Pre-leased near-term projects
Alexandria Point/San Diego/University Town Center(5)
Dev— 171,102 171,102 100 100 
SD Tech by Alexandria/San Diego/Sorrento Mesa(6)
Dev— 176,428 176,428 59 59 
— 347,530 347,530 79 79 
1,117,686 3,636,623 4,754,309 75 %78 %
Key additions in January 2021
201 Brookline Avenue/Greater Boston/FenwayDev— 510,116 510,116 17 %25 %
840 Winter Street/Greater Boston/Route 128Redev30,009 130,000 160,009 19 %19 %
30,009 640,116 670,125 
1,147,695 4,276,739 5,424,434 
(1)Initial occupancy dates are subject to leasing and/or market conditions. Construction disruptions resulting from COVID-19 and observance of social distancing measures may further impact construction and occupancy forecasts and will continue to be monitored closely. Multi-tenant projects may have occupancy by tenants over a period of time. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy.
(2)The recently acquired Alexandria Center® for Life Science – Durham redevelopment project includes three properties at 40 Moore Drive, 2400 Ellis Road, and 14 TW Alexander Drive. 2400 Ellis Road is 100% leased, with initial occupancy anticipated in 1H21 and stabilized occupancy expected for the remaining buildings in 2022.
(3)The new strategic collaborative agtech campus consists of Phase I at 5 Laboratory Drive, including campus amenities, and Phase II at 9 Laboratory Drive.
(4)Represents 150,000 RSF with 26% negotiating at 8 Davis Drive and 100,000 RSF that is 100% leased at 10 Davis Drive. Vertical construction at 8 Davis Drive has commenced, and 10 Davis Drive is expected to commence in 2Q21.
(5)Represents our 4150 Campus Point Court property and is expected to commence vertical construction in 2Q21.
(6)Represents our 10055 Barnes Canyon Road property and is expected to commence vertical construction in 2Q21.
42

New Class A Development and Redevelopment Properties: Current Projects (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

Our Ownership InterestUnlevered Yields
Property/Market/Submarket
In ServiceCIPCost to CompleteTotal at
Completion
Initial StabilizedInitial Stabilized (Cash Basis)
Under construction
The Arsenal on the Charles/Greater Boston/Cambridge/Inner Suburbs100 %$391,180 $184,995 $195,825 $772,000 6.2 %5.5 %
201 Haskins Way/San Francisco/South San Francisco100 %— 255,992 $114,008 $370,000 6.4 %6.2 %
Alexandria Center® for Life Science – San Carlos/San Francisco/Greater Stanford
100 %85,898 389,460 $154,642 $630,000 6.4 %6.1 %
3160 Porter Drive/San Francisco/Greater Stanford100 %— 60,895 TBD
Alexandria Center® – Long Island City/New York City/New York City
100 %33,683 125,929 $24,688 $184,300 5.5 %5.6 %
3115 Merryfield Row/San Diego/Torrey Pines100 %— 66,609 $85,391 $152,000 6.2 %6.2 %
5505 Morehouse Drive/San Diego/Sorrento Mesa100 %— 16,996 TBD
1165 Eastlake Avenue East/Seattle/Lake Union100 %— 106,061 $31,939 $138,000 6.5 %
(1)
6.3 %
(1)
Other/Seattle100 %53,941 64,323 TBD
9804 Medical Center Drive/Maryland/Rockville100 %— 85,725 $9,675 $95,400 7.7 %7.2 %
9950 Medical Center Drive/Maryland/Rockville100 %— 40,520 $13,780 $54,300 7.3 %6.8 %
700 Quince Orchard Road/Maryland/Gaithersburg100 %— 45,887 $33,613 $79,500 8.6 %7.3 %
Alexandria Center® for Life Science – Durham/Research Triangle/Research Triangle
100 %— 134,451 $110,549 $245,000 7.5 %6.7 %
Alexandria Center® for AgTech/Research Triangle/Research Triangle
100 %90,001 57,394 TBD
Alexandria Center® for Advanced Technologies/Research Triangle/Research Triangle
100 %— 32,605 
654,703 1,667,842 
Pre-leased near-term projects
Alexandria Point/San Diego/University Town Center55.0 %— 26,922 
SD Tech by Alexandria/San Diego/Sorrento Mesa50.0 %— 15,310 
— 42,232 
Total$654,703 $1,710,074 

(1)Unlevered yields represent anticipated aggregate returns for 1165 Eastlake Avenue East, an amenity-rich research headquarters for Adaptive Biotechnologies Corporation, and 1208 Eastlake Avenue East, an adjacent multi-tenant office/laboratory building.
43

New Class A Development and Redevelopment Properties: Summary of Pipeline
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)


Property/SubmarketOur Ownership InterestBook ValueSquare Footage
Development and Redevelopment
Under ConstructionNear
Term
Intermediate
Term
FutureTotal
Greater Boston
The Arsenal on the Charles/Cambridge/Inner Suburbs100 %$202,801 296,489 264,056 
(1)(2)
— — 560,545 
325 Binney Street/Cambridge100 %128,666 — 450,000 
(1)
— — 450,000 
57 Coolidge Avenue/Cambridge/Inner Suburbs75.0 %47,461 — 275,000 
(1)
— — 275,000 
15 Necco Street/Seaport Innovation District97.1 %185,049 — 350,000 
(1)
— — 350,000 
Reservoir Woods/Route 128100 %42,246 — 202,428 
(1)(2)
— 752,845 
(2)
955,273 
10 Necco Street/Seaport Innovation District100 %91,032 — — 175,000 — 175,000 
215 Presidential Way/Route 128100 %6,803 — — 112,000 — 112,000 
Alexandria Technology Square®/Cambridge
100 %7,881 — — — 100,000 100,000 
380 and 420 E Street/Seaport Innovation District100 %115,818 — — — 1,000,000 
(2)
1,000,000 
99 A Street/Seaport Innovation District95.5 %44,700 — — — 235,000 235,000 
One Upland Road and 100 Tech Drive/Route 128100 %8,498 — — — 750,000 750,000 
231 Second Avenue/Route 128100 %1,093 — — — 32,000 32,000 
Other value-creation projects100 %9,774 — — — 16,955 16,955 
891,822 296,489 1,541,484 287,000 2,886,800 5,011,773 
San Francisco
201 Haskins Way/South San Francisco100 %255,992 315,000 — — — 315,000 
Alexandria Center® for Life Science – San Carlos/
   Greater Stanford
100 %641,372 429,715 — 700,000 
(2)
587,000 
(2)
1,716,715 
3160 Porter Drive/Greater Stanford100 %60,895 92,147 — — — 92,147 
88 Bluxome Street/SoMa100 %300,025 — 1,070,925 — — 1,070,925 
Alexandria Technology Center® – Gateway/South San Francisco
45.1 %45,814 — 517,010 
(1)(2)
— 291,000 808,010 
3825 and 3875 Fabian Way/Greater Stanford100 %— — — 250,000 
(2)
228,000 
(2)
478,000 
3450 and 3460 Hillview Avenue/Greater Stanford100 %— — — 76,951 
(2)
— 76,951 
East Grand Avenue/South San Francisco100 %6,112 — — — 90,000 90,000 
Other value-creation projects100 %55,379 — — 191,000 25,000 216,000 
$1,365,589 836,862 1,587,935 1,217,951 1,221,000 4,863,748 

(1)We expect to commence vertical construction or redevelopment of all or a portion of this project in 2021.
(2)Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities, for which we have the intent to demolish or redevelop the existing property upon expiration of the existing in-place leases and commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
44

New Class A Development and Redevelopment Properties: Summary of Pipeline (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

Property/SubmarketOur Ownership InterestBook ValueSquare Footage
Development and Redevelopment
Under ConstructionNear
Term
Intermediate
Term
FutureTotal
New York City
Alexandria Center® – Long Island City/New York City
100 %$125,929 122,382 — — — 122,382 
47-50 30th Street/New York City100 %29,351 — 135,938 — — 135,938 
Alexandria Center® for Life Science – New York City/New York City
100 %58,381 — — 550,000 
(1)
— 550,000 
219 East 42nd Street/New York City100 %— — — — 579,947 
(2)
579,947 
213,661 122,382 135,938 550,000 579,947 1,388,267 
San Diego
3115 Merryfield Row/Torrey Pines100 %66,609 146,456 — — — 146,456 
5505 Morehouse Drive/Sorrento Mesa100 %16,996 79,945 — — — 79,945 
Alexandria Point/University Town Center55.0 %104,646 — 351,102 
(3)
249,164 
(4)
320,281 
(4)
920,547 
SD Tech by Alexandria/Sorrento Mesa50.0 %99,681 — 366,502 
(3)
160,000 333,845 860,347 
Townsgate by Alexandria/Del Mar Heights100 %22,424 — 185,000 — — 185,000 
10931 and 10933 Torrey Pines Road/Torrey Pines100 %— — — 242,000 
(4)
— 242,000 
University District/University Town Center100 %54,020 — — 600,000 
(4)(5)
— 600,000 
11255 and 11355 North Torrey Pines Road/Torrey Pines100 %106,889 — — — 240,000 
(4)
240,000 
5200 Illumina Way/University Town Center51.0 %12,302 — — — 451,832 451,832 
6450 Sequence Drive and Excess Land/Sorrento Mesa100 %35,834 — — — 911,915 
(4)
911,915 
4045 and 4075 Sorrento Valley Boulevard/Sorrento Valley100 %7,671 — — — 149,000 
(4)
149,000 
Other value-creation projects100 %— — — — 50,000 50,000 
$527,072 226,401 902,604 1,251,164 2,456,873 4,837,042 
(1)We are currently negotiating a long-term ground lease with the City of New York for the future site of a new building approximating 550,000 RSF.
(2)Includes 349,947 RSF in operation with an opportunity to either convert the existing office space into office/laboratory space through future redevelopment or to expand the building by an additional 230,000 RSF through ground-up development. The building is currently occupied by Pfizer Inc. with a remaining lease term of approximately five years.
(3)We expect to commence vertical construction or redevelopment of all or a portion of this project during 2021.
(4)Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities, for which we have the intent to demolish or redevelop the existing property upon expiration of the existing in-place leases and commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
(5)Includes our recently acquired project at 4555 Executive Drive and 9363, 9373, and 9393 Towne Centre Drive in our University Town Center submarket, which is currently under evaluation for development, subject to future market conditions.
45

New Class A Development and Redevelopment Properties: Summary of Pipeline (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

Property/SubmarketOur Ownership InterestBook ValueSquare Footage
Development and Redevelopment
Under ConstructionNear
Term
Intermediate
Term
FutureTotal
Seattle
1165 Eastlake Avenue East/Lake Union100 %$106,061 100,086 — — — 100,086 
1150 Eastlake Avenue East/Lake Union100 %49,196 — 260,000 
(1)
— — 260,000 
701 Dexter Avenue North/Lake Union100 %53,612 — 217,000 — — 217,000 
601 Dexter Avenue North/Lake Union100 %35,356 — — — 188,400 
(2)
188,400 
1010 4th Avenue South/SoDo100 %49,278 — — — 544,825 544,825 
830 4th Avenue South/SoDo100 %— — — — 52,488 
(2)
52,488 
Other value-creation projects100 %70,304 213,976 51,255 
(2)
— 35,000 300,231 
363,807 314,062 528,255 — 820,713 1,663,030 
Maryland
9804 and 9800 Medical Center Drive/Rockville100 %87,765 176,832 90,000 
(1)
— — 266,832 
9950 Medical Center Drive/Rockville100 %40,520 84,264 — — — 84,264 
700 Quince Orchard Road/Gaithersburg100 %45,887 169,420 — — — 169,420 
14200 Shady Grove Road/Rockville100 %28,668 — 145,000 145,000 145,000 435,000 
202,840 430,516 235,000 145,000 145,000 955,516 
Research Triangle
Alexandria Center® for Life Science – Durham/Research Triangle
100 %134,451 652,381 — — — 652,381 
Alexandria Center® for Advanced Technologies/Research Triangle
100 %48,769 250,000 — 70,000 700,000 1,020,000 
Alexandria Center® for AgTech, Phase II/Research Triangle
100 %57,394 160,000 — — — 160,000 
Other value-creation projects100 %4,185 — — — 76,262 76,262 
244,799 1,062,381 — 70,000 776,262 1,908,643 
Other value-creation projects100 %4,857 — — — 322,200 322,200 
Total pipeline as of December 31, 2020
$3,814,447 3,289,093 4,931,216 3,521,115 9,208,795 20,950,219 
(3)
Key subsequent and pending acquisitions
Alexandria Center® for Life Science – Fenway/Fenway
510,116 — 305,000 — 815,116 
840 Winter Street/Route 128130,000 — — — 130,000 
Mercer Mega Block/Lake Union— 800,000 — — 800,000 
3,929,209 5,731,216 3,826,115 9,208,795 22,695,335 

(1)We expect to commence vertical construction or redevelopment of all or a portion of this project during 2021.
(2)Represents total square footage upon completion of development or redevelopment of a new Class A property. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities, for which we have the intent to demolish or redevelop the existing property upon expiration of the existing in-place leases and commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.
(3)Total square footage includes 3,111,997 RSF of buildings currently in operation that will be redeveloped or replaced with new development RSF upon commencement of future construction. Refer to “Definitions and reconciliations” of this Supplemental Information for additional details on value-creation square feet currently included in rental properties.

46

Construction Spending
q220logo9a.jpg
December 31, 2020
(In thousands)


Year Ended
Construction SpendingDecember 31, 2020
Additions to real estate – consolidated projects
$1,445,171 
Investments in unconsolidated real estate joint ventures3,444 
Contributions from noncontrolling interests(22,045)
Construction spending (cash basis)1,426,570 
Change in accrued construction29,819 
Construction spending$1,456,389 

Year Ending
Projected Construction SpendingDecember 31, 2021
Development, redevelopment, and pre-construction projects$1,625,000 
Contributions from noncontrolling interests (consolidated real estate joint ventures)
(100,000)
Revenue-enhancing and repositioning capital expenditures
150,000 
Non-revenue-enhancing capital expenditures
65,000 
Guidance midpoint
$1,740,000 


47

q220logo9a.jpg
Joint Venture Financial Information
December 31, 2020

Consolidated Real Estate Joint Ventures
PropertyMarketSubmarket
Noncontrolling
Interest Share(1)
Operating RSF
at 100%
225 Binney StreetGreater BostonCambridge/Inner Suburbs70.0%305,212
75/125 Binney StreetGreater BostonCambridge/Inner Suburbs60.0%388,270
57 Coolidge AvenueGreater BostonCambridge/Inner Suburbs25.0%—
(2)
409 and 499 Illinois StreetSan FranciscoMission Bay40.0%455,069
1500 Owens StreetSan FranciscoMission Bay49.9%158,267
Alexandria Technology Center® – Gateway(3)
San FranciscoSouth San Francisco54.9%1,089,265
500 Forbes BoulevardSan FranciscoSouth San Francisco90.0%155,685
Alexandria Point(4)
San DiegoUniversity Town Center45.0%1,337,916
5200 Illumina WaySan DiegoUniversity Town Center49.0%792,687
9625 Towne Centre DriveSan DiegoUniversity Town Center49.9%163,648
SD Tech by Alexandria(5)
San DiegoSorrento Mesa50.0%677,597
The Eastlake Life Science Campus by Alexandria(6)
SeattleLake Union70.0%321,218
Unconsolidated Real Estate Joint Ventures
PropertyMarketSubmarket
Our Ownership Share(7)
Operating RSF
at 100%
1655 and 1725 Third StreetSan FranciscoMission Bay10.0 %586,208
Menlo GatewaySan FranciscoGreater Stanford49.0 %772,983
704 Quince Orchard RoadMarylandGaithersburg56.8 %
(8)
80,032


(1)In addition to the consolidated real estate joint ventures listed, various partners hold insignificant noncontrolling interests in five other joint ventures in North America.
(2)We expect to commence vertical construction of 275,000 RSF during 2021.
(3)Excludes 600, 630, 650, 901, and 951 Gateway Boulevard in our South San Francisco submarket. Noncontrolling interest share is anticipated to be 49% as we make further contributions over time.
(4)Excludes 9880 Campus Point Drive in our University Town Center submarket.
(5)Excludes 5505 Morehouse Drive and 10121 and 10151 Barnes Canyon Road in our Sorrento Mesa submarket.
(6)Excludes 1165, 1616, and 1551 Eastlake Avenue East, 188 East Blaine Street, and 1600 Fairview Avenue East in our Lake Union submarket.
(7)In addition to the unconsolidated real estate joint ventures listed, we hold an interest in two other insignificant unconsolidated real estate joint ventures in North America.
(8)Represents our ownership interest; our voting interest is limited to 50%.


48

Joint Venture Financial Information (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)


As of December 31, 2020
Noncontrolling Interest Share of
Consolidated Real Estate JVs
Our Share of Unconsolidated
Real Estate JVs
Investments in real estate$1,568,665 $457,672 
Cash, cash equivalents, and restricted cash49,633 32,981 
Other assets179,699 59,342 
Secured notes payable (refer to page 53)
— (210,201)
Other liabilities(79,931)(7,445)
Redeemable noncontrolling interests(11,342)— 
$1,706,724 $332,349 


Noncontrolling Interest Share of
Consolidated Real Estate JVs
Our Share of Unconsolidated
Real Estate JVs
December 31, 2020December 31, 2020
Three Months EndedYear EndedThree Months EndedYear Ended
Total revenues$42,203 $160,676 $10,474 $41,638 
Rental operations(11,622)(42,930)(1,679)(5,932)
30,581 117,746 8,795 35,706 
General and administrative(120)(504)(29)(217)
Interest— — (2,197)(8,284)
Depreciation and amortization(15,032)(61,933)(2,976)(11,413)
Impairment of real estate— — — (7,644)
Fixed returns allocated to redeemable noncontrolling interests(1)
220 903 — — 
$15,649 $56,212 $3,593 $8,148 
Straight-line rent and below-market lease revenue $1,055 $5,341 $3,946 $21,210 
Funds from operations(2)
$30,681 $118,145 $6,569 $27,205 


(1)Represents an allocation of joint venture earnings to redeemable noncontrolling interests primarily in one property in our South San Francisco submarket. These redeemable noncontrolling interests earn a fixed return on their investment rather than participate in the operating results of the property.
(2)Refer to “Funds from operations and funds from operations per share” in our Earnings Press Release and “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in “Definitions and reconciliations” of this Supplemental Information for the definition and reconciliation from the most directly comparable financial measure presented in accordance with GAAP.



49

Investments
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)


We present our equity investments at fair value whenever fair value or net asset value (“NAV”) is readily available. Adjustments for our limited partnership investments represent changes in reported NAV as a practical expedient to estimate fair value. For investments without readily available fair values, we adjust the carrying amount whenever such investments have an observable price change, and further adjustments are not made until another price change, if any, is observed. Refer to “Investments” in the “Definitions and reconciliations” of this Supplemental Information for additional details.

December 31, 2020
Three Months EndedYear EndedYear Ended December 31, 2019
Realized gains$21,599 $47,288 
(1)
$33,158 
(2)
Unrealized gains233,538 374,033 161,489 
Investment income$255,137 $421,321 $194,647 
InvestmentsCostUnrealized
Gains
Carrying Amount
Fair value:
Publicly traded companies
$208,754 $351,076 
(3)
$559,830 
Entities that report NAV
334,341 327,741 662,082 
Entities that do not report NAV:
Entities with observable price changes
47,545 96,859 144,404 
Entities without observable price changes
244,798 — 244,798 
December 31, 2020$835,438 
(4)
$775,676 $1,611,114 
September 30, 2020$788,807 $542,138 $1,330,945 

(1)Includes impairments related to investments in privately held entities that do not report NAV of $24.5 million for the year ended December 31, 2020.
(2)Includes impairments related to investments in privately held entities that do not report NAV of $17.1 million for the year ended December 31, 2019.
(3)Includes gross unrealized gains and losses of $366.9 million and $15.8 million, respectively, as of December 31, 2020.
(4)Represents 3.2% of total gross assets as of December 31, 2020.

Public/Private
Mix (Cost)
q420pubprivmixv21a.jpg
Tenant/Non-Tenant
Mix (Cost)
q420tenantmixv21a.jpg
50

q220logo9a.jpg
Key Credit Metrics
December 31, 2020

LiquidityMinimal Outstanding Borrowings and Significant Availability on Unsecured Senior Line of Credit
(in millions)
$4.1B
q420lineofcreditv31a.jpg
(in millions)
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program$2,900 
Outstanding forward equity sales agreements(1)
56 
Cash, cash equivalents, and restricted cash598 
Investments in publicly traded companies560 
Liquidity as of December 31, 2020
$4,114 
Net Debt and Preferred Stock to Adjusted EBITDA(2)
Fixed-Charge Coverage Ratio(2)
q420netdebtv21a.jpg
q420fixedchargev31a.jpg
(1)Represents expected net proceeds from the future settlement of the remaining 362 thousand shares outstanding under our forward equity sales agreements as of December 31, 2020. Excludes forward equity sales agreements aggregating $1.1 billion entered into in January 2021.
(2)Quarter annualized.
51

Summary of Debt
q220logo9a.jpg
December 31, 2020
(in millions)





Weighted-Average Remaining Term of 10.6 Years
q420debtmaturitiesv31a.jpg
(1)Refer to footnote 3 on the next page under “Fixed-rate and variable-rate debt” for additional details.
52

Summary of Debt (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

Fixed-rate and variable-rate debtFixed-Rate
Debt
Variable-Rate DebtTotalPercentageWeighted-Average
Interest Rate(1)
Remaining Term
(in years)
Secured notes payable$230,925 $— $230,925 3.1 %3.53 %3.4
Unsecured senior notes payable7,232,370 — 7,232,370 95.6 3.81 10.9
Unsecured senior line of credit— — — — N/A5.0
Commercial paper program— 99,991 99,991 1.3 0.29 
(2)
Total/weighted average$7,463,295 $99,991 $7,563,286 100.0 %3.76 %10.6
(2)
Percentage of total debt99 %1 %100 %
(1)Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to the amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.
(2)The commercial paper notes bear interest at short-term fixed rates and can generally be issued with a maturity of 30 days or less and with a maximum maturity of 397 days from the date of issuance. Borrowings under the program are used to fund short-term capital needs and are backed by our unsecured senior line of credit. The commercial paper outstanding as of December 31, 2020, matured on January 13, 2021. In the event we are unable to issue commercial paper notes or refinance outstanding borrowings under terms equal to or more favorable than those under our unsecured senior line of credit, we expect to borrow under the unsecured senior line of credit at L+0.825%. As such, we calculate the weighted-average remaining term of our commercial paper using the maturity date of our unsecured senior line of credit. Using the maturity date of our outstanding commercial paper, the consolidated weighted-average maturity of our debt remains at 10.6 years. The commercial paper notes sold during the three months ended December 31, 2020, were issued at a weighted-average yield to maturity of 0.26% and had a weighted-average maturity term of 12 days.

Debt covenantsUnsecured Senior Notes PayableUnsecured Senior Line of Credit
Debt Covenant Ratios(1)
RequirementDecember 31, 2020RequirementDecember 31, 2020
Total Debt to Total Assets≤ 60%31%≤ 60.0%27.5%
Secured Debt to Total Assets≤ 40%1%≤ 45.0%0.8%
Consolidated EBITDA to Interest Expense≥ 1.5x8.6x≥ 1.50x3.91x
Unencumbered Total Asset Value to Unsecured Debt≥ 150%305%N/AN/A
Unsecured Interest Coverage RatioN/AN/A≥ 1.75x6.64x
(1)All covenant ratio titles utilize terms as defined in the respective debt and credit agreements. The calculation of consolidated EBITDA is based on the definitions contained in our loan agreements and is not directly comparable to the computation of EBITDA as described in Exchange Act Release No. 47226.


Unconsolidated real estate joint ventures’ debt
Unconsolidated Joint VentureOur ShareMaturity DateStated Rate
Interest Rate(1)
Debt Balance at 100%(2)
704 Quince Orchard Road56.8%3/16/23L+1.95%3.22 %
(3)
$12,660 
1655 and 1725 Third Street
10.0%3/10/254.50%4.57 %598,232 
Menlo Gateway, Phase II
49.0%5/1/354.53%4.59 %155,942 
Menlo Gateway, Phase I
49.0%8/10/354.15%4.18 %139,558 
$906,392 
(1)Includes interest expense and amortization of loan fees.
(2)Represents outstanding principal, net of unamortized deferred financing costs, as of December 31, 2020.
(3)Includes a 1.00% LIBOR floor on the interest rate.
53

Summary of Debt (continued)
q220logo9a.jpg
December 31, 2020
(Dollars in thousands)

DebtStated 
Rate
Interest
Rate(1)
Maturity
Date(2)
Principal Payments Remaining for the Periods Ending December 31,PrincipalUnamortized (Deferred Financing Cost), (Discount)/Premium Total
20212022202320242025Thereafter
Secured notes payable
Greater Boston
4.82 %3.40 %2/6/24$3,394 $3,564 $3,742 $183,527 $— $— $194,227 $8,344 $202,571 
San Francisco4.14 %4.42 7/1/26— — — — — 28,200 28,200 (549)27,651 
San Francisco6.50 %6.50 7/1/3626 28 30 32 34 553 703 — 703 
Secured debt weighted-average interest rate/subtotal
4.74 %3.53 3,420 3,592 3,772 183,559 34 28,753 223,130 7,795 230,925 
Commercial paper program(3)
0.27 %
(3)
0.29 
(3)
(3)
— 
(3)
— — — — 100,000 
(3)
100,000 (9)99,991 
Unsecured senior line of creditL+0.825 %N/A1/6/26— — — — — — — — — 
Unsecured senior notes payable – green bond
4.00 %4.03 1/15/24— — — 650,000 — — 650,000 (356)649,644 
Unsecured senior notes payable
3.45 %3.62 4/30/25— — — — 600,000 — 600,000 (3,804)596,196 
Unsecured senior notes payable
4.30 %4.50 1/15/26— — — — — 300,000 300,000 (2,465)297,535 
Unsecured senior notes payable – green bond
3.80 %3.96 4/15/26— — — — — 350,000 350,000 (2,599)347,401 
Unsecured senior notes payable
3.95 %4.13 1/15/27— — — — — 350,000 350,000 (3,062)346,938 
Unsecured senior notes payable
3.95 %4.07 1/15/28— — — — — 425,000 425,000 (2,986)422,014 
Unsecured senior notes payable
4.50 %4.60 7/30/29— — — — — 300,000 300,000 (1,908)298,092 
Unsecured senior notes payable
2.75 %2.87 12/15/29— — — — — 400,000 400,000 (3,688)396,312 
Unsecured senior notes payable
4.70 %4.81 7/1/30— — — — — 450,000 450,000 (3,535)446,465 
Unsecured senior notes payable
4.90 %5.05 12/15/30— — — — — 700,000 700,000 (7,843)692,157 
Unsecured senior notes payable
3.375 %3.48 8/15/31— — — — — 750,000 750,000 (6,897)743,103 
Unsecured senior notes payable
1.875 %1.97 2/1/33— — — — — 1,000,000 1,000,000 (10,559)989,441 
Unsecured senior notes payable
4.85 %4.93 4/15/49— — — — — 300,000 300,000 (3,332)296,668 
Unsecured senior notes payable
4.00 %3.91 2/1/50— — — — — 700,000 700,000 10,404 710,404 
Unsecured debt weighted average/subtotal
3.76 — — — 650,000 600,000 6,125,000 7,375,000 (42,639)7,332,361 
Weighted-average interest rate/total
3.76 %$3,420 $3,592 $3,772 $833,559 $600,034 $6,153,753 $7,598,130 $(34,844)$7,563,286 
Balloon payments
$— $— $— $833,221 $600,000 $6,153,200 $7,586,421 $— $7,586,421 
Principal amortization
3,420 3,592 3,772 338 34 553 11,709 (34,844)(23,135)
Total debt$3,420 $3,592 $3,772 $833,559 $600,034 $6,153,753 $7,598,130 $(34,844)$7,563,286 
Fixed-rate/hedged variable-rate debt
$3,420 $3,592 $3,772 $833,559 $600,034 $6,053,753 $7,498,130 $(34,835)$7,463,295 
Unhedged variable-rate debt
— — — — — 100,000 100,000 (9)99,991 
Total debt
$3,420 $3,592 $3,772 $833,559 $600,034 $6,153,753 $7,598,130 $(34,844)$7,563,286 
Weighted-average stated rate on maturing debt
N/AN/AN/A4.19%3.45%3.65%
(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.
(2)Reflects any extension options that we control.
(3)Refer to footnote 2 on the prior page under “Fixed-rate and variable-rate debt.”
54

q220logo9a.jpg
Definitions and Reconciliations
December 31, 2020


This section contains additional details for sections throughout this Supplemental Information and the accompanying Earnings Press Release, as well as explanations and reconciliations of certain non-GAAP financial measures and the reasons why we use these supplemental measures of performance and believe they provide useful information to investors. Additional detail can be found in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.

Adjusted EBITDA and Adjusted EBITDA margin
 
The following table reconciles net income (loss) and revenues, the most directly comparable financial measures calculated and presented in accordance with GAAP, to Adjusted EBITDA and revenues, as adjusted, respectively:
 
Three Months Ended
(Dollars in thousands)
12/31/209/30/206/30/203/31/2012/31/19
Net income$457,133 $95,799 $243,561 $30,678 $216,053 
Interest expense
37,538 43,318 45,014 45,739 45,493 
Income taxes
2,053 2,430 1,406 1,341 1,269 
Depreciation and amortization177,750 176,831 168,027 175,496 140,518 
Stock compensation expense11,394 12,994 
(1)
9,185 9,929 10,239 
Loss on early extinguishment of debt
7,898 52,770 — — — 
Gain on sales of real estate
(152,503)(1,586)— — (474)
Unrealized (gains) losses on non-real estate investments(233,538)14,013 (171,652)17,144 (148,268)
Impairment of real estate
25,177 7,680 13,218 9,647 12,334 
Impairment of non-real estate investments
— — 4,702 19,780 9,991 
Termination fee— (86,179)— — — 
Adjusted EBITDA
$332,902 $318,070 $313,461 $309,754 $287,155 
Revenues
$463,720 $545,042 $436,956 $439,919 $408,114 
Non-real estate investments – realized gains (losses)21,599 17,361 13,005 (4,677)4,399 
Impairment of non-real estate investments
— — 4,702 19,780 9,991 
Termination fee— (86,179)— — — 
Revenues, as adjusted$485,319 $476,224 $454,663 $455,022 $422,504 
Adjusted EBITDA margin
69%67%69%68%68%
(1)Includes the acceleration of stock compensation expense aggregating $4.5 million related to the resignation of an executive officer.

We use Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization (“EBITDA”), excluding stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, impairments of real estate, and significant termination fees. Adjusted EBITDA also excludes unrealized gains or losses and significant realized gains and impairments that result from our non-real estate investments. These non-real estate investment amounts are classified in our consolidated statements of operations outside of revenues.

We believe Adjusted EBITDA provides investors with relevant and useful information as it allows investors to evaluate the operating performance of our business activities without having to account for differences recognized because of investing and financing decisions related to our real
estate and non-real estate investments, our capital structure, capital market transactions, and variances resulting from the volatility of market conditions outside of our control. For example, we exclude gains or losses on the early extinguishment of debt to allow investors to measure our performance independent of our indebtedness and capital structure. We believe that adjusting for the effects of impairments and gains or losses on sales of real estate, significant impairments and gains on the sale of non-real estate investments, and significant termination fees allows investors to evaluate performance from period to period on a consistent basis without having to account for differences recognized because of investing and financing decisions related to our real estate and non-real estate investments or other corporate activities that may not be representative of the operating performance of our properties.

In addition, we believe that excluding charges related to stock compensation and unrealized gains or losses facilitates for investors a comparison of our business activities across periods without the volatility resulting from market forces outside of our control. Adjusted EBITDA has limitations as a measure of our performance. Adjusted EBITDA does not reflect our historical expenditures or future requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant measure of performance, it does not represent net income (loss) or cash flows from operations calculated and presented in accordance with GAAP, and it should not be considered as an alternative to those indicators in evaluating performance or liquidity.

In order to calculate Adjusted EBITDA margin, we also make comparable adjustments to our revenues. We adjust our total revenues by realized gains, losses, and impairments related to our non-real estate investments and significant termination fees to arrive at revenues, as adjusted. Our calculation of Adjusted EBITDA margin divides Adjusted EBITDA by our revenues, as adjusted. We believe that consistent application of these comparable adjustments to both components of Adjusted EBITDA margin provides a more useful calculation for the comparison across periods.

Annual rental revenue

Annual rental revenue represents the annualized fixed base rental obligations, calculated in accordance with GAAP, for leases in effect as of the end of the period, related to our operating RSF. Annual rental revenue is presented using 100% of the annual rental revenue of our consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Annual rental revenue per RSF is computed by dividing annual rental revenue by the sum of 100% of the RSF of our consolidated properties and our share of the RSF of properties held in unconsolidated real estate joint ventures. As of December 31, 2020, approximately 94% of our leases (on an RSF basis) were triple net leases, which require tenants to pay substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses (including increases thereto) in addition to base rent. Annual rental revenue excludes these operating expenses recovered from our tenants. Amounts recovered from our tenants related to these operating expenses, along with base rent, are classified in income from rentals in our consolidated statements of operations.

Cash interest

Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of loan fees and debt premiums (discounts). Refer to the definition of fixed-charge coverage ratio for a reconciliation of interest expense, the most directly comparable financial measure calculated and presented in accordance with GAAP, to cash interest.

55

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Class A properties and AAA locations

Class A properties are properties clustered in AAA locations that provide innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Class A properties generally command higher annual rental rates than other classes of similar properties.

AAA locations are in close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses. Such locations are generally characterized by high barriers to entry for new landlords, high barriers to exit for tenants, and a limited supply of available space.

Development, redevelopment, and pre-construction

A key component of our business model is our disciplined allocation of capital to the development and redevelopment of new Class A properties, and property enhancements identified during the underwriting of certain acquired properties, located in collaborative life science, technology, and agtech campuses in AAA urban innovation clusters. These projects are generally focused on providing high-quality, generic, and reusable spaces that meet the real estate requirements of, and are reusable by, a wide range of tenants. Upon completion, each value-creation project is expected to generate a significant increase in rental income, net operating income, and cash flows. Our development and redevelopment projects are generally in locations that are highly desirable to high-quality entities, which we believe results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Development projects generally consist of the ground-up development of generic and reusable facilities. Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into office/laboratory, tech office, or agtech space. We generally will not commence new development projects for aboveground construction of new Class A office/laboratory, tech office, and agtech space without first securing significant pre-leasing for such space, except when there is solid market demand for high-quality Class A properties.

Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and are required for the vertical construction of buildings. Ultimately, these projects will provide high-quality facilities and are expected to generate significant revenue and cash flows.

Development, redevelopment, and pre-construction spending also includes the following costs: (i) certain tenant improvements and renovations that will be reimbursed, (ii) amounts to bring certain acquired properties up to market standard and/or other costs identified during the acquisition process (generally within two years of acquisition), and (iii) permanent conversion of space for highly flexible, move-in-ready office/laboratory space to foster the growth of promising early- and growth-stage life science companies.

Revenue-enhancing and repositioning capital expenditures represent spending to reposition or significantly change the use of a property, including through improvement in the asset quality from Class B to Class A.

Non-revenue-enhancing capital expenditures represent costs required to maintain the current revenues of a stabilized property, including the associated costs for renewed and re-leased space.

Dividend payout ratio (common stock)

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of common stock outstanding on the respective record dates multiplied by the related dividend per share) to funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted.

Dividend yield

Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end of the quarter.

Fixed-charge coverage ratio

Fixed-charge coverage ratio is a non-GAAP financial measure representing the ratio of Adjusted EBITDA to fixed charges. We believe this ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing obligations and preferred stock dividends. Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of loan fees and debt premiums (discounts).

The following table reconciles interest expense, the most directly comparable financial measure calculated and presented in accordance with GAAP, to cash interest and fixed charges:
 Three Months Ended
(Dollars in thousands)12/31/209/30/206/30/203/31/2012/31/19
Adjusted EBITDA$332,902 $318,070 $313,461 $309,754 $287,155 
Interest expense
$37,538 $43,318 $45,014 $45,739 $45,493 
Capitalized interest37,589 32,556 30,793 24,680 23,822 
Amortization of loan fees(2,905)(2,605)(2,737)(2,247)(2,241)
Amortization of debt premiums
869 910 888 888 907 
Cash interest and fixed charges73,091 74,179 73,958 69,060 67,981 
Fixed-charge coverage ratio:
– quarter annualized4.6x4.3x4.2x4.5x4.2x
– trailing 12 months4.4x4.3x4.2x4.2x4.2x
56

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders

GAAP-basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish over time. In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Nareit Board of Governors established funds from operations as an improved measurement tool. Since its introduction, funds from operations has become a widely used non-GAAP financial measure among equity REITs. We believe that funds from operations is helpful to investors as an additional measure of the performance of an equity REIT. Moreover, we believe that funds from operations, as adjusted, allows investors to compare our performance to the performance of other real estate companies on a consistent basis, without having to account for differences recognized because of real estate acquisition and disposition decisions, financing decisions, capital structure, capital market transactions, variances resulting from the volatility of market conditions outside of our control, or other corporate activities that may not be representative of the operating performance of our properties.

On January 1, 2019, we adopted standards established by the Nareit Board of Governors in its November 2018 White Paper (the “Nareit White Paper”) on a prospective basis. The Nareit White Paper defines funds from operations as net income (computed in accordance with GAAP), excluding gains or losses on sales of real estate, and impairments of real estate, plus depreciation and amortization of operating real estate assets, and after adjustments for our share of consolidated and unconsolidated partnerships and real estate joint ventures. Impairments represent the write-down of assets when fair value over the recoverability period is less than the carrying value due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.

We compute funds from operations, as adjusted, as funds from operations calculated in accordance with the Nareit White Paper, excluding significant gains, losses, and impairments realized on non-real estate investments, unrealized gains or losses on non-real estate investments, gains or losses on early extinguishment of debt, gains or losses on early termination of interest rate hedge agreements, significant termination fees, acceleration of stock compensation expense due to the resignation of an executive officer, preferred stock redemption charges, deal costs, the income tax effect related to such items, and the amount of such items that is allocable to our unvested restricted stock awards. Neither funds from operations nor funds from operations, as adjusted, should be considered as alternatives to net income (determined in accordance with GAAP) as indications of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as measures of liquidity, nor are they indicative of the availability of funds for our cash needs, including our ability to make distributions.

The following table reconciles net income to funds from operations for the share of consolidated real estate joint ventures attributable to noncontrolling interests and our share of unconsolidated real estate joint ventures:
Noncontrolling Interest Share of
Consolidated Real Estate JVs
Our Share of Unconsolidated
Real Estate JVs
December 31, 2020December 31, 2020
(in thousands)Three Months EndedYear EndedThree Months EndedYear Ended
Net income$15,649 $56,212 $3,593 $8,148 
Depreciation and amortization
15,032 61,933 2,976 11,413 
Impairment of real estate
— — — 7,644 
Funds from operations$30,681 $118,145 $6,569 $27,205 
Initial stabilized yield (unlevered)
Initial stabilized yield is calculated as the estimated amounts of net operating income at stabilization divided by our investment in the property. Our initial stabilized yield excludes the benefit of leverage. Our cash rents related to our value-creation projects are generally expected to increase over time due to contractual annual rent escalations. Our estimates for initial stabilized yields, initial stabilized yields (cash basis), and total costs at completion represent our initial estimates at the commencement of the project. We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.
•Initial stabilized yield reflects rental income, including contractual rent escalations and any rent concessions over the term(s) of the lease(s), calculated on a straight-line basis.
•Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental concessions, if any, have elapsed and our total cash investment in the property.

Investment-grade or publicly traded large cap tenants

Investment-grade or publicly traded large cap tenants represent tenants that are investment-grade rated or publicly traded companies with an average daily market capitalization greater than $10 billion for the twelve months ended December 31, 2020, as reported by Bloomberg Professional Services. In addition, we monitor the credit quality and related material changes of our tenants. Material changes that cause a tenant’s market capitalization to decline below $10 billion, which are not immediately reflected in the twelve-month average, may result in their exclusion from this measure.

Investments

We hold investments in publicly traded companies and privately held entities primarily involved in the life science, technology, and agtech industries. We recognize, measure, present, and disclose these investments as follows:
Statements of Operations
Balance SheetGains and Losses
Carrying AmountUnrealizedRealized
Difference between proceeds received upon disposition and historical cost
Publicly traded companies
Fair valueChanges in fair value
Privately held entities without readily determinable fair values that:
Report NAVFair value, using NAV as a practical expedientChanges in NAV, as a practical expedient to fair value
Do not report NAVCost, adjusted for observable price changes and impairmentsObservable price changesImpairments to reduce costs to fair value, which result in an adjusted cost basis and the differences between proceeds received upon disposition and adjusted or historical cost
57

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

For investments in privately held entities that do not report NAV per share, an observable price is a price observed in an orderly transaction for an identical or similar investment of the same issuer. Observable price changes result from, among other things, equity transactions for the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity transactions related to the same issuer. For these transactions to be considered observable price changes of the same issuer, we evaluate whether these transactions have similar rights and obligations, including voting rights, distribution preferences, conversion rights, and other factors, to the investments we hold.

Investments in real estate

The following table reconciles our investments in real estate as of December 31, 2020:
(In thousands)Investments in Real Estate
Gross investments in real estate$21,238,355 
Less: accumulated depreciation(3,178,024)
Net investments in real estate – North America18,060,331 
Net investments in real estate – Asia32,041 
Investments in real estate$18,092,372 



Space Intentionally Blank

The square footage presented in the table below includes RSF of buildings in operation as of December 31, 2020, primarily representing lease expirations at recently acquired properties that also have inherent future development or redevelopment opportunities, for which we have the intent to demolish or redevelop the existing property upon expiration of the existing in-place leases and commencement of future construction:
Dev/
Redev
RSF lease expirations going into
development and redevelopment
Property/Submarket20212022ThereafterTotal
Near-term projects:
The Arsenal on the Charles/Cambridge/
Inner Suburbs
Redev64,056 — — 64,056 
50 and 60 Sylvan Road/Route 128Redev202,428 — — 202,428 
651 Gateway Boulevard/South San FranciscoRedev— 197,787 102,223 
(1)
300,010 
Other/SeattleRedev— 51,255 — 51,255 
266,484 249,042 102,223 617,749 
Intermediate-term projects:
3825 Fabian Way/Greater StanfordRedev— 250,000 — 250,000 
3450 and 3460 Hillview Avenue/Greater StanfordRedev— 42,340 34,611 76,951 
987 and 1075 Commercial Street/Greater StanfordDev26,738 — — 26,738 
10931 and 10933 North Torrey Pines Road/
Torrey Pines
Dev— 92,450 — 92,450 
10260 Campus Point Drive/University Town CenterDev— — 109,164 109,164 
9363 and 9393 Towne Centre Drive/
University Town Center
Dev— — 87,252 87,252 
4555 Executive Drive/University Town CenterDev41,475 — — 41,475 
68,213 384,790 231,027 684,030 
Future projects:
380 and 420 E Street/Seaport Innovation DistrictDev— — 195,506 195,506 
40 Sylvan Road/Route 128Redev— — 312,845 312,845 
3875 Fabian Way/Greater StanfordRedev— — 228,000 228,000 
960 Industrial Road/Greater StanfordDev— — 110,000 110,000 
219 East 42nd Street/New York CityDev— — 349,947 349,947 
11255 and 11355 North Torrey Pines Road/
Torrey Pines
Dev— 139,135 — 139,135 
4161 Campus Point Court/University Town CenterDev— — 159,884 159,884 
6450 Sequence Drive/Sorrento MesaRedev— — 202,915 202,915 
4045 and 4075 Sorrento Valley Boulevard/
Sorrento Valley
Dev— — 50,926 50,926 
601 Dexter Avenue North/Lake UnionDev— — 18,680 18,680 
830 4th Avenue South/SoDoDev— — 42,380 42,380 
— 139,135 1,671,083 1,810,218 
334,697 772,967 2,004,333 3,111,997 
(1)     Represents vacant square footage as of December 31, 2020.
58

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Joint venture financial information

We present components of balance sheet and operating results information related to our real estate joint ventures, which are not presented, or intended to be presented, in accordance with GAAP. We present the proportionate share of certain financial line items as follows: (i) for each real estate joint venture that we consolidate in our financial statements, which are controlled by us through contractual rights or majority voting rights, but of which we own less than 100%, we apply the noncontrolling interest economic ownership percentage to each financial item to arrive at the amount of such cumulative noncontrolling interest share of each component presented; and (ii) for each real estate joint venture that we do not control and do not consolidate, and are instead controlled jointly or by our joint venture partners through contractual rights or majority voting rights, we apply our economic ownership percentage to each financial item to arrive at our proportionate share of each component presented.

The components of balance sheet and operating results information related to our real estate joint ventures do not represent our legal claim to those items. For each entity that we do not wholly own, the joint venture agreement generally determines what equity holders can receive upon capital events, such as sales or refinancing, or in the event of a liquidation. Equity holders are normally entitled to their respective legal ownership of any residual cash from a joint venture only after all liabilities, priority distributions, and claims have been repaid or satisfied.

We believe this information can help investors estimate the balance sheet and operating results information related to our partially owned entities. Presenting this information provides a perspective not immediately available from consolidated financial statements and one that can supplement an understanding of the joint venture assets, liabilities, revenues, and expenses included in our consolidated results.

The components of balance sheet and operating results information related to our real estate joint ventures are limited as an analytical tool as the overall economic ownership interest does not represent our legal claim to each of our joint ventures’ assets, liabilities, or results of operations. In addition, joint venture financial information may include financial information related to the unconsolidated real estate joint ventures that we do not control. We believe that in order to facilitate for investors a clear understanding of our operating results and our total assets and liabilities, joint venture financial information should be examined in conjunction with our consolidated statements of operations and balance sheets. Joint venture financial information should not be considered an alternative to our consolidated financial statements, which are prepared in accordance with GAAP.

Key items included in net income attributable to Alexandria’s common stockholders

We present a tabular comparison of items, whether gain or loss, that may facilitate a high-level understanding of our results and provide context for the disclosures included in this Supplemental Information, our most recent annual report on Form 10-K, and our subsequent quarterly reports on Form 10-Q. We believe such tabular presentation promotes a better understanding for investors of the corporate-level decisions made and activities performed that significantly affect comparison of our operating results from period to period. We also believe this tabular presentation will supplement for investors an understanding of our disclosures and real estate operating results. Gains or losses on sales of real estate and impairments of held for sale assets are related to corporate-level decisions to dispose of real estate. Gains or losses on early extinguishment of debt, gains or losses on early termination of interest rate hedge agreements, and preferred stock redemption charges are related to corporate-level financing decisions focused on our capital structure strategy. Significant realized and unrealized gains or losses on non-real estate investments and impairments of real estate and non-real estate investments are not related to the operating performance of our real estate assets as they result from strategic, corporate-level non-real estate investment decisions and external market conditions. Impairments of non-real estate investments are not related to the operating performance of our real estate as they
represent the write-down of non-real estate investments when their fair values decline below their respective carrying values due to changes in general market or other conditions outside of our control. Significant items, whether a gain or loss, included in the tabular disclosure for current periods are described in further detail in this Supplemental Information and accompanying Earnings Press Release.

Lease accounting

On January 1, 2019, we adopted new lease accounting standards that set out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a lease agreement (i.e., lessees and lessors). The new lease accounting standards did not result in material changes in neither the amount nor the timing of lease-related revenues that we recognized from our tenants. However, the new standards affected our financial statement presentation primarily in three specific areas.

Key differences between the prior accounting standard and the new lease accounting standards:

Prior to January 1, 2019, we classified rental revenues and tenant recoveries as separate line items on our consolidated statements of operations. Effective January 1, 2019, based on our election of a practical expedient, we are required to disclose the combined components of rental revenues and tenant recoveries as a single lease component, which is classified on our consolidated statements of operations as income from rentals. As a result, we do not disclose tenant recoveries as a separate GAAP revenue measure. Refer to the definition of tenant recoveries below for additional details on tenant recoveries revenue and its usefulness to investors.

The new lease accounting standard requires that lessors and lessees capitalize, as initial direct costs, only incremental costs of a lease that would not have been incurred if the lease had not been obtained. Effective January 1, 2019, costs that we incur to negotiate or arrange a lease, regardless of its outcome, such as for fixed employee compensation, tax, or legal advice to negotiate lease terms, and other costs, are expensed as incurred.

Under the package of practical expedients and optional transition method that we elected on January 1, 2019, we are not required to reassess whether initial direct leasing costs capitalized prior to the adoption of the new lease accounting standard in connection with the leases that commenced prior to January 1, 2019, qualify for capitalization under the new lease accounting standard. Therefore, we continue to amortize these initial direct leasing costs over the respective lease term.

In addition, the new lease accounting standards require companies to recognize a lease liability and a corresponding right-of-use asset on the consolidated balance sheets, and to represent the net present value of future rental payments related to operating leases in which we are the lessee. As a result, on January 1, 2019, we recognized a lease liability classified in accounts payable, accrued expenses, and other liabilities on our consolidated balance sheets, and a corresponding right-of-use asset included in other assets on our consolidated balance sheets, related to our ground leases existing as of January 1, 2019, for which we are the lessee. The net present value of the remaining future rental payments of our ground leases was calculated for each operating lease using the respective remaining lease term and a corresponding estimated incremental borrowing rate, which is the estimated interest rate that we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments.

Net cash provided by operating activities after dividends

Net cash provided by operating activities after dividends includes the deduction for distributions to noncontrolling interests. For purposes of this calculation, changes in operating assets and liabilities are excluded as they represent timing differences.

59

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Net debt and preferred stock to Adjusted EBITDA

Net debt and preferred stock to Adjusted EBITDA is a non-GAAP financial measure that we believe is useful to investors as a supplemental measure in evaluating our balance sheet leverage. Net debt and preferred stock is equal to the sum of total consolidated debt less cash, cash equivalents, and restricted cash, plus preferred stock outstanding as of the end of the period. Refer to the definition of Adjusted EBITDA and Adjusted EBITDA margin for further information on the calculation of Adjusted EBITDA.

The following table reconciles debt to net debt and preferred stock and computes the ratio to Adjusted EBITDA:
(Dollars in thousands)12/31/209/30/206/30/203/31/2012/31/19
Secured notes payable$230,925 $342,363 $344,784 $347,136 $349,352 
Unsecured senior notes payable 7,232,370 7,230,819 6,738,486 6,736,999 6,044,127 
Unsecured senior line of credit and commercial paper99,991 249,989 440,000 221,000 384,000 
Unamortized deferred financing costs56,312 58,284 52,175 53,807 47,299 
Cash and cash equivalents(568,532)(446,255)(206,860)(445,255)(189,681)
Restricted cash(29,173)(38,788)(34,680)(43,116)(53,008)
Preferred stock— — — — — 
Net debt and preferred stock$7,021,893 $7,396,412 $7,333,905 $6,870,571 $6,582,089 
Adjusted EBITDA:
– quarter annualized$1,331,608 $1,272,280 $1,253,844 $1,239,016 $1,148,620 
– trailing 12 months$1,274,187 $1,228,440 $1,185,347 $1,137,650 $1,085,382 
Net debt and preferred stock to Adjusted EBITDA:
– quarter annualized5.3 x5.8 x5.8 x5.5 x5.7 x
– trailing 12 months5.5 x6.0 x6.2 x6.0 x6.1 x



Space Intentionally Blank
Net operating income, net operating income (cash basis), and operating margin

The following table reconciles net income to net operating income, and to net operating income (cash basis):
Three Months EndedYear Ended
(Dollars in thousands)12/31/2012/31/1912/31/2012/31/19
Net income$457,133 $216,053 $827,171 $404,047 
Equity in earnings of unconsolidated real estate joint ventures(3,593)(4,777)(8,148)(10,136)
General and administrative expenses
32,690 29,782 133,341 108,823 
Interest expense37,538 45,493 171,609 173,675 
Depreciation and amortization
177,750 140,518 698,104 544,612 
Impairment of real estate
25,177 

12,334 48,078 12,334 
Loss on early extinguishment of debt
7,898 — 60,668 47,570 
Gain on sales of real estate(152,503)(474)(154,089)(474)
Investment income(255,137)(152,667)(421,321)(194,647)
Net operating income326,953 286,262 1,355,413 1,085,804 
Straight-line rent revenue
(23,890)(24,400)(96,676)(104,235)
Amortization of acquired below-market leases
(13,514)(8,837)(57,244)(29,813)
Net operating income (cash basis)$289,549 $253,025 $1,201,493 $951,756 
Net operating income (cash basis) – annualized
$1,158,196 $1,012,100 $1,201,493 $951,756 
Net operating income (from above)$326,953 $286,262 $1,355,413 $1,085,804 
Total revenues$463,720 $408,114 $1,885,637 $1,531,296 
Operating margin71%70%72%71%

Net operating income is a non-GAAP financial measure calculated as net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, excluding equity in the earnings of our unconsolidated real estate joint ventures, general and administrative expenses, interest expense, depreciation and amortization, impairments of real estate, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, and investment income or loss. We believe net operating income provides useful information to investors regarding our financial condition and results of operations because it primarily reflects those income and expense items that are incurred at the property level. Therefore, we believe net operating income is a useful measure for investors to evaluate the operating performance of our consolidated real estate assets. Net operating income on a cash basis is net operating income adjusted to exclude the effect of straight-line rent and amortization of acquired above- and below-market lease revenue adjustments required by GAAP. We believe that net operating income on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent revenue and the amortization of acquired above- and below-market leases.

60

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Furthermore, we believe net operating income is useful to investors as a performance measure for our consolidated properties because, when compared across periods, net operating income reflects trends in occupancy rates, rental rates, and operating costs, which provide a perspective not immediately apparent from net income or loss. Net operating income can be used to measure the initial stabilized yields of our properties by calculating net operating income generated by a property divided by our investment in the property. Net operating income excludes certain components from net income in order to provide results that are more closely related to the results of operations of our properties. For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level. In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort comparability of operating performance at the property level. Impairments of real estate have been excluded in deriving net operating income because we do not consider impairments of real estate to be property-level operating expenses. Impairments of real estate relate to changes in the values of our assets and do not reflect the current operating performance with respect to related revenues or expenses. Our impairments of real estate represent the write-down in the value of the assets to the estimated fair value less cost to sell. These impairments result from investing decisions or a deterioration in market conditions. We also exclude realized and unrealized investment income or loss, which results from investment decisions that occur at the corporate level related to non-real estate investments in publicly traded companies and certain privately held entities. Therefore, we do not consider these activities to be an indication of operating performance of our real estate assets at the property level. Our calculation of net operating income also excludes charges incurred from changes in certain financing decisions, such as losses on early extinguishment of debt, as these charges often relate to corporate strategy. Property operating expenses included in determining net operating income primarily consist of costs that are related to our operating properties, such as utilities, repairs, and maintenance; rental expense related to ground leases; contracted services, such as janitorial, engineering, and landscaping; property taxes and insurance; and property-level salaries. General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies that are incurred as part of corporate office management. We calculate operating margin as net operating income divided by total revenues.

We believe that in order to facilitate for investors a clear understanding of our operating results, net operating income should be examined in conjunction with net income or loss as presented in our consolidated statements of operations. Net operating income should not be considered as an alternative to net income or loss as an indication of our performance, nor as an alternative to cash flows as a measure of our liquidity or our ability to make distributions.

Operating statistics

We present certain operating statistics related to our properties, including number of properties, RSF, occupancy percentage, leasing activity, and contractual lease expirations as of the end of the period. We believe these measures are useful to investors because they facilitate an understanding of certain trends for our properties. We compute the number of properties, RSF, occupancy percentage, leasing activity, and contractual lease expirations at 100% for all properties in which we have an investment, including properties owned by our consolidated and unconsolidated real estate joint ventures. For operating metrics based on annual rental revenue, refer to our discussion of annual rental revenue herein.


Same property comparisons

As a result of changes within our total property portfolio during the comparative periods presented, including changes from assets acquired or sold, properties placed into development or redevelopment, and development or redevelopment properties recently placed into service, the consolidated total income from rentals, as well as rental operating expenses in our operating results, can show significant changes from period to period. In order to supplement an evaluation of our results of operations over a given quarterly or annual period, we analyze the operating performance for all consolidated properties that were fully operating for the entirety of the comparative periods presented, referred to as same properties. We separately present quarterly and year-to-date same property results to align with the interim financial information required by the SEC in our management’s discussion and analysis of our financial condition and results of operations. These same properties are analyzed separately from properties acquired subsequent to the first day in the earliest comparable quarterly or year-to-date period presented, properties that underwent development or redevelopment at any time during the comparative periods, unconsolidated real estate joint ventures, properties classified as held for sale, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results. Additionally, termination fees, if any, are excluded from the results of same properties.

Space Intentionally Blank
61

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

The following table reconciles the number of same properties to total properties for the year ended December 31, 2020:
Development – under construction
PropertiesAcquisitions after January 1, 2019Properties
9804 Medical Center Drive1 25, 35, and 45 West Watkins Mill
9950 Medical Center Drive1Road3 
Alexandria Center® for Life Science – San Carlos
3170 and 3181 Porter Drive2 
2Shoreway Science Center2 
3115 Merryfield Row13911, 3931, and 4075 Sorrento
201 Haskins Way1Valley Boulevard3 
1165 Eastlake Avenue East15 Necco Street1 
9 Laboratory Drive1 601 Dexter Avenue North1 
Alexandria Center® for Advanced
4224/4242 Campus Point Court and
Technologies2 10210 Campus Point Drive3 
10 3825 and 3875 Fabian Way2 
Development – placed into
SD Tech by Alexandria10 
service after January 1, 2019
PropertiesThe Arsenal on the Charles6 
399 Binney Street1 275 Grove Street1 
279 East Grand Avenue1 601, 611, and 651 Gateway Boulevard3 
188 East Blaine Street1 3330, 3412, 3450, and 3460
3 Hillview Avenue4 
Redevelopment – under constructionProperties9605 Medical Center Drive1 
5505 Morehouse Drive1 987 and 1075 Commercial Street2 
Alexandria Center® – Long Island City
1 4555 Executive Drive1 
3160 Porter Drive1 
Alexandria Center® for Life
The Arsenal on the Charles5 
   Science – Durham
13 
700 Quince Orchard Road1 Reservoir Woods3 
Alexandria Center® for Life
One Upland Road1 
   Science – Durham
3 830 4th Avenue South1 
12 11255 and 11355 North Torrey
Redevelopment – placed into
   Pines Road2 
service after January 1, 2019
Properties6420 and 6450 Sequence Drive2 
Alexandria PARC4 380 and 420 E Street2 
9877 Waples Street1 Other15 
681 and 685 Gateway Boulevard
2 84 
266 and 275 Second Avenue
2 Unconsolidated real estate JVs6 
5 Laboratory Drive1 Properties held for sale4 
10 Total properties excluded from same
properties129 
Same properties209 
(1)
Total properties in North America as of
December 31, 2020
338 
(1)Includes 9880 Campus Point Drive and 3545 Cray Court. The 9880 Campus Point Drive building was occupied through January 2018 and was placed into service during 3Q20, and 3545 Cray Court is currently undergoing renovations.

Stabilized occupancy date

The stabilized occupancy date represents the estimated date on which the project is expected to reach occupancy of 95% or greater.

Tenant recoveries

Tenant recoveries represent revenues comprising reimbursement of real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses and earned in the period during which the applicable expenses are incurred and the tenant’s obligation to reimburse us arises.

We classify rental revenues and tenant recoveries generated through the leasing of real estate assets within revenue in income from rentals in our consolidated statements of operations. We provide investors with a separate presentation of rental revenues and tenant recoveries in “Same Property Performance” of this Supplemental Information because we believe it promotes investors’ understanding of our operating results. We believe that the presentation of tenant recoveries is useful to investors as a supplemental measure of our ability to recover operating expenses under our triple net leases, including recoveries of utilities, repairs and maintenance, insurance, property taxes, common area expenses, and other operating expenses, and of our ability to mitigate the effect to net income for any significant variability to components of our operating expenses.

The following table reconciles income from rentals to tenant recoveries:
Three Months EndedYear Ended
(In thousands)12/31/2009/30/2006/30/2003/31/2012/31/1912/31/2012/31/19
Income from rentals$461,335 $543,412 $435,856 $437,605 $404,721 $1,878,208 $1,516,864 
Rental revenues(353,950)(438,393)(341,555)(337,942)(308,418)(1,471,840)(1,165,788)
Tenant recoveries$107,385 $105,019 $94,301 $99,663 $96,303 $406,368 $351,076 

Total equity capitalization

Total equity capitalization is equal to the outstanding shares of common stock multiplied by the closing price on the last trading day at the end of each period presented.

Total market capitalization

Total market capitalization is equal to the sum of total equity capitalization and total debt.

62

q220logo9a.jpg
Definitions and Reconciliations (continued)
December 31, 2020

Unencumbered net operating income as a percentage of total net operating income

Unencumbered net operating income as a percentage of total net operating income is a non-GAAP financial measure that we believe is useful to investors as a performance measure of the results of operations of our unencumbered real estate assets as it reflects those income and expense items that are incurred at the unencumbered property level. Unencumbered net operating income is derived from assets classified in continuing operations, which are not subject to any mortgage, deed of trust, lien, or other security interest, as of the period for which income is presented.

The following table summarizes unencumbered net operating income as a percentage of total net operating income:
 
Three Months Ended
(Dollars in thousands)
12/31/209/30/206/30/203/31/2012/31/19
Unencumbered net operating income
$315,586 $388,575 $296,358 $295,001 $270,903 
Encumbered net operating income
11,367 16,024 16,687 15,815 15,359 
Total net operating income$326,953 $404,599 $313,045 $310,816 $286,262 
Unencumbered net operating income as a percentage of total net operating income
97%96%95%95%95%

Weighted-average interest rate for capitalization of interest

The weighted-average interest rate required for calculating capitalization of interest pursuant to GAAP represents a weighted-average rate based on the rates applicable to borrowings outstanding during the period, including expense/income related to interest rate hedge agreements, amortization of loan fees, amortization of debt premiums (discounts), and other bank fees. A separate calculation is performed to determine our weighted-average interest rate for capitalization for each month. The rate will vary each month due to changes in variable interest rates, outstanding debt balances, the proportion of variable-rate debt to fixed-rate debt, the amount and terms of interest rate hedge agreements, and the amount of loan fee and premium (discount) amortization.

The following table presents the weighted-average interest rate for capitalization of interest:
 Three Months Ended
12/31/209/30/206/30/203/31/2012/31/19
Weighted-average interest rate for capitalization of interest
3.66%3.64%4.03%3.80%3.88%

Weighted-average shares of common stock outstanding – diluted

From time to time, we enter into capital market transactions, including forward equity sales agreements (“Forward Agreements”), to fund acquisitions, to fund construction of our highly leased development and redevelopment projects, and for general working capital purposes. We are required to consider the potential dilutive effect of our forward equity sales agreements under the treasury stock method while the forward equity sales agreements are outstanding. As of December 31, 2020, we had Forward Agreements outstanding to sell an aggregate of 362 thousand shares of common stock.

Prior to the conversion of our remaining outstanding shares in October 2019, we considered the effect of assumed conversion of our outstanding 7.00% Series D Convertible Preferred Stock when determining potentially dilutive incremental shares to our common stock. When calculating the assumed conversion, we add back to net income or loss the dividends paid on our Series D Convertible Preferred Stock to the numerator and then include additional common shares assumed to have been issued (as displayed in the table below) to the denominator of the per share calculation. The effect of the assumed conversion is considered separately for our per share calculations of net income or loss; funds from operations, computed in accordance with the definition in the Nareit White Paper; and funds from operations, as adjusted. Prior to the conversion of our remaining outstanding shares in October 2019, our Series D Convertible Preferred Stock was dilutive and assumed to be converted when quarterly and annual basic EPS, funds from operations, or funds from operations, as adjusted, exceeded approximately $1.75 and $7.00 per share, respectively, subject to conversion ratio adjustments and the impact of repurchases of our Series D Convertible Preferred Stock. The effect of the assumed conversion was included when it was dilutive on a per share basis. The dilutive effect to both numerator and denominator may result in a per share effect of less than a half cent, which would appear as zero in our per share calculation, even when the dilutive effect to the numerator alone appears in our reconciliation.

The weighted-average shares of common stock outstanding used in calculating EPS – diluted, FFO per share – diluted, and FFO per share – diluted, as adjusted, during each period are calculated as follows:
Three Months EndedYear Ended
(In thousands)12/31/209/30/206/30/203/31/2012/31/1912/31/2012/31/19
Basic shares for EPS
133,688 124,901 124,333 121,433 114,175 126,106 112,204 
Forward Agreements
139 927 115 352 761 384 320 
Series D Convertible Preferred Stock
— — — — 38 — — 
Diluted shares for EPS
133,827 125,828 124,448 121,785 114,974 126,490 112,524 
Basic shares for EPS133,688 124,901 124,333 121,433 114,175 126,106 112,204 
Forward Agreements
139 927 115 352 761 384 320 
Series D Convertible Preferred Stock
— — — — 38 — 442 
Diluted shares for FFO
133,827 125,828 124,448 121,785 114,974 126,490 112,966 
Basic shares for EPS
133,688 124,901 124,333 121,433 114,175 126,106 112,204 
Forward Agreements
139 927 115 352 761 384 320 
Series D Convertible Preferred Stock
— — — — 38 — — 
Diluted shares for FFO, as adjusted
133,827 125,828 124,448 121,785 114,974 126,490 112,524 
63